The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, JAMA, vol.293, p.1653, 2005. ,
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, vol.121, pp.1276-1284, 2013. ,
Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014. ,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013. ,
Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016. ,
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions, J. Biol. Chem, vol.282, pp.26696-26706, 2007. ,
Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016. ,
Physiology and Pathophysiology of Heme: Implications for Kidney Disease, J. Am. Soc. Nephrol, vol.18, pp.414-420, 2007. ,
Defective Recovery and Severe Renal Damage After Acute Hemolysis in Hemopexin-Deficient Mice, Blood, vol.94, pp.3906-3914, 1999. ,
Hemopexin counteracts systolic dysfunction induced by hemedriven oxidative stress. Free Radic, Biol. Med, vol.108, pp.452-464, 2017. ,
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014. ,
Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases, Circulation, vol.127, pp.1317-1329, 2013. ,
First evidence of subclinical renal tubular injury during sickle-cell crisis, Orphanet J. Rare Dis, vol.9, p.67, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00986267
Biomarkers for early detection of sickle nephropathy, Am. J ,
, , vol.86, pp.559-566, 2011.
Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice, J. Am. Soc. Nephrol. ASN, p.2016070711, 2017. ,
Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red CellsClinical Perspective, Circulation, vol.134, pp.945-960, 2016. ,
Hemoglobin-driven pathophysiology is an in vivo consequence of the ,
, Clin. Invest, vol.122, pp.1444-1458, 2012.
Role of red cell membrane lipid peroxidation in hemolysis due to phenylhydrazine, Biochem. Pharmacol, vol.29, pp.1355-1359, 1980. ,
Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response, Cell Death Dis, vol.7, p.2064, 2016. ,
The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo, Am. J. Pathol, vol.156, pp.1527-1535, 2000. ,
Hemolysis is associated with acute kidney injury during major aortic surgery, Kidney Int, vol.77, pp.913-920, 2010. ,
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int, vol.62, pp.237-244, 2002. ,
A Membrane-Bound Metallo-endopeptidase, Current Topics in Cellular Regulation, vol.28, pp.263-290, 1986. ,
Keratins are novel markers of renal epithelial cell injury, Kidney Int, vol.89, pp.792-808, 2016. ,
Alpha-1-microglobulin: an indicator protein for renal tubular function ,
DOI : 10.1136/jcp.36.3.253
URL : https://jcp.bmj.com/content/36/3/253.full.pdf
, Clin. Pathol, vol.36, pp.253-259, 1983.
Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and hemedegradation properties, Blood, vol.99, pp.1894-1901, 2002. ,
Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for ?(1)-microglobulin, Antioxid. Redox Signal, vol.17, pp.813-846, 2012. ,
Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta, Biochem. Biophys. Res. Commun, vol.379, pp.904-908, 2009. ,
Meprin Metalloproteases Inactivate Interleukin 6, J. Biol ,
DOI : 10.1074/jbc.m113.546309
URL : http://www.jbc.org/content/289/11/7580.full.pdf
, Chem, vol.289, pp.7580-7588, 2014.
Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis, Kidney Int, vol.58, pp.1033-1044, 2000. ,
Hemolysis-induced lethality involves inflammasome activation by heme, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4110-4118, 2014. ,
Adhesion molecules involved in neutrophil recruitment during sepsis-induced acute kidney injury, J. Innate Immun, vol.6, pp.597-606, 2014. ,
Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.14, pp.48-54, 2000. ,
Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury, Proc. Natl ,
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.216, pp.456-463, 1997. ,
Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis, J. Biomark, vol.2015, pp.1-13, 2015. ,
Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis. Free Radic, Biol. Med, vol.24, pp.393-400, 1998. ,
, Ann. Hematol, vol.63, pp.39-41, 1991.
Clinical Features of Anti-Factor H AutoantibodyAssociated Hemolytic Uremic Syndrome, J. Am. Soc. Nephrol, vol.21, pp.2180-2187, 2010. ,
An experimental model of hemolysis-induced acute pancreatitis. Braz ,
, J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol, vol.36, pp.879-886, 2003.
How hemolysis causes acute pancreatitis ,
, Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.8, pp.51-52, 2002.
The role of heme in hemolysis-induced acute pancreatitis, Med. Sci ,
, Monit. Int. Med. J. Exp. Clin. Res, vol.13, pp.67-72, 2007.
Characterization of Heme as Activator of Toll-like Receptor 4 ,
, J. Biol. Chem, vol.282, pp.20221-20229, 2007.
Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease, Blood, vol.125, pp.3805-3814, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01186628
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species, Lab. Investig. J. Tech. Methods Pathol, vol.64, pp.648-655, 1991. ,
, Intravascular hemolysis induces complement system activation mediated by heme and heme-loaded erythrocyte microvesicles
, Viviane Gnemmi, vol.4, 2005.
, Sylvain Le Jeune, vol.11
, UPMC Univ Paris 06, F-75006
,
,
, INSERM UMR_S, vol.970
, Ecole Pratique des Hautes Études (EPHE), F-75014
, Hôpital Avicenne, F-93000
Service de pathologie, Hôpital Necker enfants malades, F-75015 ,
, INSERM UMRS 1138; 15 rue de l'Ecole de Medecine, entrance E, fl. 3, e-mail: lubka.roumenina@crc.jussieu.fr Conflict of interest N.B., T.G. and S.M are employees of CSL Behring. LTR receives research funding from CSL, vol.75006, pp.33-34
Heme on innate immunity and inflammation, Front Pharmacol, 2014. ,
Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol Med, vol.22, issue.3, pp.200-213, 2016. ,
Sickle cell disease: renal manifestations and mechanisms, Nat Rev Nephrol, vol.11, issue.3, pp.161-71, 2015. ,
Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity, Free Radic Biol Med, vol.89, pp.931-974, 2015. ,
,
,
,
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion, Blood, vol.96, issue.7, pp.2451-2460, 2000. ,
Complement System Part I -Molecular Mechanisms of Activation and Regulation. Front Immunol, vol.6, 2015. ,
,
, Complement System Part II: Role in Immunity. Front Immunol, 2015.
, , vol.6
,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, issue.2, pp.282-92, 2013. ,
Activation of the Alternative Complement Pathway by Red Blood Cells from Patients with Sickle Cell Disease, Clin Immunol Immunopathol, vol.71, issue.2, pp.199-202, 1994. ,
Complement activation during painful crisis in sickle cell anemia, Clin Immunol Immunopathol, vol.76, issue.3, pp.314-334, 1995. ,
The role of complement activation in thrombosis and hemolytic anemias, Transfus Apher Sci, vol.54, issue.2, pp.191-199, 2016. ,
Activation of the alternative complement Clin Invest, vol.92, pp.1326-1361, 1993. ,
The transgenic SAD mouse: a model of human sickle cell glomerulopathy, Kidney Int, vol.46, issue.5, pp.1337-1382, 1994. ,
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, JAMA, vol.293, p.1653, 2005. ,
Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic, Biol. Med, vol.89, pp.931-943, 2015. ,
Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014. ,
Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016. ,
Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J. Immunol. Baltim. Md, vol.179, pp.5543-5552, 1950. ,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-292, 2013. ,
Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins, Scand. J. Immunol, vol.65, pp.230-239, 2007. ,
Heme interacts with c1q and inhibits the classical complement pathway, J. Biol. Chem, vol.286, pp.16459-16469, 2011. ,
Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia, Clin. Immunol ,
, Orlando Fla, vol.171, pp.32-35, 2016.
The interaction of the factor VIII/von Willebrand factor complex with hematin, Thromb. Haemost, vol.56, pp.277-282, 1986. ,
Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report, Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb, vol.22, pp.443-447, 2011. ,
Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia, J. Thromb. Haemost. JTH, vol.6, pp.2202-2209, 2008. ,
Excess of heme induces tissue factor-dependent activation of coagulation in mice, Haematologica, vol.100, pp.308-314, 2015. ,
Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions, J. Biol. Chem, vol.282, pp.26696-26706, 2007. ,
Antibody polyreactivity in health and disease: statu variabilis, J. Immunol. Baltim. Md, pp.993-999, 2013. ,
Relationship between natural and heme-mediated antibody polyreactivity, Biochem. Biophys. Res. Commun, vol.472, pp.281-286, 2016. ,
Mechanism and Functional Implications of the Heme-Induced Binding Promiscuity of IgE, Biochemistry (Mosc.), vol.54, pp.2061-2072, 2015. ,
Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease, Blood, vol.123, pp.3818-3827, 2014. ,
Neutrophil activation by heme: implications for inflammatory processes, Blood, vol.99, pp.4160-4165, 2002. ,
Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors, J. Biol. Chem, vol.282, pp.24430-24436, 2007. ,
Hemopexin therapy reverts heme-induced pro-inflammatory, 2015. ,
Characterization of Heme as Activator of Toll-like Receptor 4 ,
, J. Biol. Chem, vol.282, pp.20221-20229, 2007.
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014. ,
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998. ,
Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016. ,
Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front. Immunol, vol.6, 2015. ,
, Complement System Part II: Role in Immunity. Front. Immunol, vol.6, 2015.
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity, J. Exp ,
, , vol.185, pp.1619-1627, 1997.
Molecular intercommunication between the complement and coagulation systems, J. Immunol. Baltim. Md, vol.185, pp.5628-5636, 1950. ,
Recommendations for the diagnosis and treatment of the acute porphyrias, Ann. Intern. Med, vol.142, pp.439-450, 2005. ,
Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product, Cell, vol.42, pp.791-798, 1985. ,
Asthma morbidity and treatment in children with sickle cell disease, Expert Rev. Respir. Med, vol.5, pp.635-645, 2011. ,
, , 1977.
, Nihon Yakurigaku Zasshi Folia Pharmacol. Jpn, vol.73, pp.541-547
Heme-albumin: an honorary enzyme, Cell Death Dis, vol.6, p.1895, 2015. ,
,
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.15215-15220, 2001. ,
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease, N. Engl. J. Med, vol.376, pp.429-439, 2017. ,
Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc, vol.25, pp.2524-2529, 2010. ,
First evidence of subclinical renal tubular injury during sickle-cell crisis, Orphanet J. Rare Dis, vol.9, p.67, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-00986267
, , 2007.
N-Phenylprotoporphyrin IX formation in the hemoglobin-phenylhydrazine reaction. Evidence for a protein-stabilized iron-phenyl intermediate, J. Biol. Chem, vol.257, pp.6231-6241, 1982. ,
Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis, Pediatr. Nephrol, vol.32, pp.1451-1456, 2017. ,
, Clin. Invest, vol.122, pp.1444-1458, 2012.
Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues, Thromb. Haemost, vol.82, pp.1047-1052, 1999. ,
, , 2013.
, Natl. Acad. Sci. U. S. A, vol.110, pp.16426-16431
Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg, Protein Sci. Publ. Protein Soc, vol.22, pp.204-212, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02095673
, Investig. J. Tech. Methods Pathol, vol.64, pp.648-655, 1991.
Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants, Blood, vol.95, pp.3442-3450, 2000. ,
, , 2007.
How the Vascular Endothelium Survives (and Dies) in an IronRich Environment, Antioxid. Redox Signal, vol.9, pp.2119-2138 ,
, , 2002.
Modulation of monocyte-endothelial cell interactions by platelet microparticles, J. Clin. Invest, vol.102, pp.136-144, 1998. ,
Plasminogen Is a Complement Inhibitor, J. Biol. Chem, vol.287, pp.18831-18842, 2012. ,
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease, J. Am. Soc. Nephrol. JASN, vol.27, pp.1847-1853, 2016. ,
Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies, 2006. ,
, , vol.28, pp.175-184
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease, Haematologica, vol.94, pp.1513-1519, 2009. ,
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion, Blood, vol.96, pp.2451-2459, 2000. ,
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-390, 2014. ,
Morphological classifications of vertebrate blood capillaries, Am. J. Physiol, vol.196, pp.381-390, 1959. ,
, , 2012.
, J. Immunol. Baltim. Md, vol.188, pp.5682-5693, 1950.
Molecular insights into the surface-specific arrangement of complement C5 convertase enzymes, BMC Biol, vol.13, p.93, 2015. ,
Role of Complement in Autoimmune Hemolytic Anemia, Transfus. Med. Hemotherapy, vol.42, pp.303-310, 2015. ,
Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy, BioMed Res. Int, p.363278, 2015. ,
Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria, J. Infect. Dis, vol.212, pp.1835-1840, 2015. ,
Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis, J. Immunol. Baltim. Md, pp.1021-1040, 2017. ,
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb), Mol. Immunol, vol.45, pp.2370-2379, 2008. ,
Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect. Immun, vol.55, pp.206-210, 1987. ,
, , 2010.
, , 1998.
Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases, J. Immunol. Baltim. Md, pp.5129-5138, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01843975
Properdin: a tightly regulated critical inflammatory modulator, Immunol. Rev, vol.274, pp.172-190, 2016. ,
Structural basis for sialic acid-mediated self-recognition by complement factor H, Nat. Chem. Biol, 2014. ,
Complement, C1q, and C1q-Related Molecules Regulate Macrophage Polarization, Front. Immunol, vol.5, 2014. ,
Meprin: A Membrane-Bound Metallo-endopeptidase, In Current Topics in Cellular Regulation, pp.263-290, 1986. ,
The endothelium as physiological source of properdin: role of wall shear stress, Mol. Immunol, vol.39, pp.669-675, 2003. ,
Neutrophils, from Marrow to Microbes, Immunity, vol.33, pp.657-670, 2010. ,
, , 2004.
, Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex, J. Immunol. Baltim. Md, vol.173, pp.6921-6927, 1950.
, , 1983.
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review, Biochimie, vol.80, pp.173-195, 1998. ,
The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood, J. Leukoc. Biol, vol.81, pp.1404-1413, 2007. ,
, , vol.81, pp.2137-2143, 1993.
Paroxysmal nocturnal hemoglobinuria, Blood, vol.124, pp.2804-2811, 2014. ,
Eculizumab: another breakthrough, Blood, vol.129, pp.922-923, 2017. ,
Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1, J. Immunol. Baltim. Md, vol.144, pp.3835-3840, 1950. ,
, , 2015.
, Kidney Dis. Off. J. Natl. Kidney Found, vol.65, pp.968-969
The Making of a Macromolecular Machine: Assembly of the Membrane Attack Complex, Biochemistry (Mosc.), vol.53, pp.1908-1915, 2014. ,
Mapping of the C5a receptor signal transduction network in human neutrophils, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.9190-9194, 1994. ,
, decidual endothelium. Mol. Immunol, vol.45, pp.2629-2640, 2008.
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages, J. Lipid Res, vol.39, pp.755-766, 1998. ,
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation, Blood, vol.117, pp.1340-1349, 2011. ,
, , 1981.
, , 2012.
, , 2015.
, , 2006.
, Costimulation via CD55 on human CD4+ T cells mediated by CD97, J. Immunol. Baltim. Md, vol.177, pp.1070-1077, 1950.
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nat. Immunol, vol.11, pp.862-871, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00564091
, CD46 in innate and adaptive immunity: an update, 2011.
, Clin. Exp. Immunol, vol.164, pp.301-311
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal, Cell, vol.153, pp.362-375, 2013. ,
Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+, J. Immunol. Baltim. Md, vol.137, pp.263-270, 1950. ,
, , 1988.
Regulation of humoral immunity by complement, Immunity, vol.37, pp.199-207, 2012. ,
Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea, Transfus. Clin. Biol. J. Soc. Francaise Transfus. Sang, vol.15, pp.39-50, 2008. ,
,
, Immune modulation of human dendritic cells by complement, Eur. J. Immunol, vol.37, pp.2803-2811
, , 2014.
, Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors, Int. J. Mol. Sci, vol.15, pp.19700-19728
, , 2010.
The role of complement activation in thrombosis and hemolytic anemias, Transfus. Apher. Sci, vol.54, pp.191-198, 2016. ,
T Cell Activation by Terminal Complex of Complement and Immune Complexes, J. Biol. Chem, vol.286, pp.38627-38637, 2011. ,
A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H, J. Am. Soc. Nephrol, vol.27, pp.1665-1677, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02149496
, Stoichiometry of Complexes between Mannose-binding Protein and Its Associated Serine Proteases: DEFINING FUNCTIONAL UNITS FOR COMPLEMENT ACTIVATION, 2001.
, J. Biol. Chem, vol.276, pp.25894-25902
, , 2014.
, , 2007.
Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J. Clin. Invest, vol.124, pp.145-155, 2014. ,
Molecular basis for complement recognition by integrin ?X?2, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.4586-4591, 2012. ,
, Structure of Complement C3(H2O) Revealed By Quantitative Cross-Linking/Mass Spectrometry And Modeling, vol.15, pp.2730-2743, 2016.
Endothelial cell diversity revealed by global expression profiling, Proc. Natl. Acad. Sci, vol.100, pp.10623-10628, 2003. ,
A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes, Mol. Immunol, vol.26, pp.835-840, 1989. ,
Increased activation of the alternative complement pathway in sickle cell disease, Clin. Immunol. Immunopathol, vol.37, pp.93-97, 1985. ,
, , 1994.
Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, vol.91, pp.3527-3561, 1998. ,
, , 2015.
, J. Leukoc. Biol, vol.97, pp.147-160
,
, Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS, Blood, vol.125, pp.3253-3262
Beyond lysis: how complement influences cell fate, Clin. Sci. Lond. Engl, vol.104, pp.455-466, 1979. ,
Platelet activation leads to activation and propagation of the complement system, J. Exp. Med, vol.201, pp.871-879, 2005. ,
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis, Rheumatol. Oxf. Engl, vol.48, pp.293-298, 2009. ,
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth, J. Immunol. Baltim. Md, pp.3542-3548, 2015. ,
The Toll-like receptors and their role in septic shock, Expert Opin. Ther. Targets, vol.7, pp.603-612, 2003. ,
Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation, J. Immunol. Baltim. Md, pp.4963-4973, 2015. ,
, Exp. Med, vol.181, pp.2119-2127, 1995.
Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation, J. Immunol. Baltim. Md, vol.178, pp.6017-6022, 1950. ,
, , 2006.
, , 2013.
, Eur. J. Immunol, vol.20, pp.1669-1675, 1990.
Properdin factor D: effects on thrombin-induced platelet aggregation, J. Clin. Invest, vol.64, pp.721-728, 1979. ,
Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g, J. Immunol. Baltim. Md, vol.132, pp.1960-1966, 1950. ,
Sickle cell nephropathy: New insights into its pathophysiology, Kidney Int, vol.27, pp.711-717, 1985. ,
The transgenic SAD mouse: a model of human sickle cell glomerulopathy, Kidney Int, vol.46, pp.1337-1345, 1994. ,
Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation, J. Immunol. Baltim. Md, vol.181, pp.8433-8440, 1950. ,
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure, Blood, vol.119, pp.3684-3690, 2012. ,
Alternate Pathway Activation in Sickle Cell Disease and ?-Thalassemia Major, J. Natl. Med. Assoc, vol.70, pp.503-506, 1978. ,
Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs, Circ. Res, vol.91, pp.626-632, 2002. ,
Endothelial cell-cell junctions: happy together, Nat. Rev. Mol. Cell Biol, vol.5, pp.261-270, 2004. ,
DOI : 10.1038/nrm1357
Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N. Engl. J. Med, vol.361, pp.345-357, 2009. ,
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-350, 1996. ,
, , 2016.
Stimulation of fetal hemoglobin synthesis in baboons by hemolysis and hypoxia, Proc. Natl. Acad. Sci. U. S. A, vol.75, pp.2937-2940, 1978. ,
Hemopoietic stress and fetal hemoglobin synthesis: comparative studies in vivo and in vitro, Blood, vol.54, pp.1176-1181, 1979. ,
Maintenance of fetal hemoglobin (HbF) elevations in the baboon by prolonged erythropoietic stress, Blood, vol.60, pp.519-523, 1982. ,
Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase, J. Immunol. Baltim. Md, vol.155, pp.2085-2095, 1950. ,
Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Free Radic, Biol. Med, vol.89, pp.931-943, 2015. ,
Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response, Cell Death Dis, vol.7, p.2064, 2016. ,
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises, Am. J. Kidney Dis. Off. J. Natl. Kidney Found, vol.69, pp.51-59, 2017. ,
, , 1987.
, Biol, vol.120, pp.1031-1043, 1993.
Complement is activated by IgG hexamers assembled at the cell surface, Science, vol.343, pp.1260-1263, 2014. ,
, , 2007.
, J. Biol. Chem, vol.282, pp.26696-26706
, , 2007.
, J. Immunol, vol.65, pp.230-239
,
, Antibody polyreactivity in health and disease: statu variabilis, J. Immunol. Baltim. Md, pp.993-999, 1950191.
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, vol.399, pp.601-605, 1999. ,
, J. Immunol. Baltim. Md, vol.162, pp.1127-1136, 1950.
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma, Clin. Exp. Immunol, vol.89, pp.173-180, 1994. ,
, , 2016.
,
, , 1998.
Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties, J. Biol. Chem, vol.274, pp.2583-2591, 1999. ,
Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome, J. Am. Soc. Nephrol, vol.21, pp.2180-2187, 2010. ,
Pancreatitis in acute hemolysis, Ann. Hematol, vol.63, pp.39-41, 1991. ,
, , vol.127, pp.1062-1064, 2016.
Integrin-dependent phagocytosis: spreading from microadhesion to new concepts, J. Cell Sci, vol.121, pp.1773-1783, 2008. ,
Heme on innate immunity and inflammation, Front. Pharmacol, vol.5, 2014. ,
Hemolysis-induced lethality involves inflammasome activation by heme, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.4110-4118, 2014. ,
Three-dimensional reconstruction of the 14-filament fibers of hemoglobin S, J. Mol. Biol, vol.130, pp.451-472, 1979. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin. J. Am. Soc. Nephrol. CJASN, vol.8, pp.554-562, 2013. ,
, , 2013.
An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age, 2010. ,
, Hum. Mol. Genet, vol.19, pp.4694-4704
, , 1976.
Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex, Pharmacol. Ther, vol.100, pp.171-194, 2003. ,
CD14 Is Expressed and Released as Soluble CD14 by Human Intestinal Epithelial Cells In Vitro: Lipopolysaccharide Activation of Epithelial Cells Revisited, Infect. Immun, vol.69, pp.3772-3781, 2001. ,
Endothelium-derived relaxing and contracting factors, 1989. ,
, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.3, 2007.
The origin and kinetics of mononuclear phagocytes, J. Exp. Med, vol.128, pp.415-435, 1968. ,
, , 2010.
, , 2012.
, , 2003.
Studies on hemoglobin metabolism. I. The kinetic properties of the plasma hemoglobin pool in normal man, J. Clin. Invest, vol.38, pp.1479-1483, 1959. ,
, , 2016.
, A journey through the lectin pathway of complement-MBL and beyond, Immunol. Rev, vol.274, pp.74-97
Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system, Am. J. Pathol, vol.150, pp.31-41, 1997. ,
, , 2017.
A receptor for the third component of complement in the human renal glomerulus, J. Exp. Med, vol.142, pp.1029-1034, 1975. ,
,
, J. Clin. Invest, vol.78, pp.340-348
Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation, Mol. Immunol, vol.58, pp.98-107, 2014. ,
, , 2013.
, Extracellular hemin crisis triggers acute chest syndrome in sickle mice, J. Clin. Invest, vol.123, pp.4809-4820
Monocytes and macrophages: developmental pathways and tissue homeostasis, Nat. Rev. Immunol, vol.14, pp.392-404, 2014. ,
Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.4186-4191, 2004. ,
Cardiovascular Abnormalities in Sickle Cell Disease, J. Am. Coll. Cardiol, vol.59, pp.1123-1133, 2012. ,
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease, Br. J. Haematol, vol.116, pp.436-444, 2002. ,
, , 2014.
Gain-offunction mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.240-245, 2007. ,
Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.4685-4690, 2013. ,
Role of red cell membrane lipid peroxidation in hemolysis due to phenylhydrazine, Biochem. Pharmacol, vol.29, pp.1355-1359, 1980. ,
Weibel-Palade bodies-sentinels of acute stress, Nat. Rev. Nephrol, vol.5, pp.423-426, 2009. ,
Expression of CD14, 2002. ,
, , 2008.
Characterization of Plasma Labile Heme in Hemolytic Conditions, FEBS J, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01793489
Mechanisms of cell protection by heme oxygenase, 2010. ,
, Annu. Rev. Pharmacol. Toxicol, vol.50, pp.323-354
, , 2002.
, Neutrophil activation by heme: implications for inflammatory processes, Blood, vol.99, pp.4160-4165
, , 1998.
, Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vasoocclusive sickle crisis, Blood, vol.92, pp.2551-2555
Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red CellsClinical Perspective, Circulation, vol.134, pp.945-960, 2016. ,
, , 2017.
, Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension, Am. J. Physiol, vol.312, issue.6, pp.1120-1127
The interaction of the factor VIII/von Willebrand factor complex with hematin, Thromb. Haemost, vol.56, pp.277-282, 1986. ,
Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Tolllike Receptor 4-MD2 Complex, J. Infect. Dis, vol.214, issue.1, pp.140-150, 2016. ,
,
Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense, Science, vol.317, pp.1552-1554, 2007. ,
Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9, Cell Rep, vol.1, pp.200-207, 2012. ,
Mechanism and Functional Implications of the Heme-Induced Binding Promiscuity of IgE, Biochemistry (Mosc.), vol.54, pp.2061-2072, 2015. ,
Relationship between natural and heme-mediated antibody polyreactivity, Biochem. Biophys. Res. Commun, vol.472, pp.281-286, 2016. ,
Neutrophil granules in health and disease, J. Intern. Med, vol.268, pp.25-34, 2010. ,
Sickle cell disease related mortality in the United States, 1999. ,
, Blood Cancer, vol.60, pp.1482-1486
Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia, Pediatr. Nephrol. Berl. Ger, vol.29, 1997. ,
Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int, vol.62, pp.237-244, 2002. ,
Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway, Circ. Res, vol.98, pp.1134-1140, 2006. ,
The alternative complement pathway revisited, J. Cell. Mol. Med, vol.12, pp.1074-1084, 2008. ,
, C3a and C5a Stimulate Chemotaxis of Human Mast Cells, vol.89, p.2863, 1997.
, , 1994.
, , 1989.
Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology, Blood, vol.77, pp.214-237, 1991. ,
Adhesive interactions of sickle erythrocytes with endothelium, J. Clin. Invest, vol.99, pp.2561-2564, 1997. ,
, , 1980.
Abnormal Adherence of Sickle Erythrocytes to Cultured Vascular Endothelium, J. Clin. Invest, vol.65, pp.154-160, 1980. ,
, , 2012.
, Biol. Chem, vol.287, issue.23, pp.19528-19536
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation, Blood, vol.114, pp.2439-2447, 2009. ,
Lipid metabolism in human endothelial cells, Biochim. Biophys. Acta, vol.1761, pp.765-774, 2006. ,
, , 2002.
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens, Cell, vol.124, pp.915-927, 2006. ,
, , 2014.
Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta, Biochem. Biophys. Res. Commun, vol.379, pp.904-908, 2009. ,
Complement-Mediated Regulation of Metabolism and Basic Cellular Processes, Immunity, vol.45, pp.240-254, 2016. ,
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N. Engl. J. Med, vol.355, pp.1233-1243, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00599451
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria, Br. J. Haematol, vol.162, pp.62-73, 2013. ,
Endothelium-role in regulation of coagulation and inflammation, 2012. ,
, Semin. Immunopathol, vol.34, pp.93-106
Lessons learned from mouse models of hemolytic transfusion reactions, Curr. Opin. Hematol, vol.15, pp.601-605, 2008. ,
, , 2008.
, , 2010.
Extra-Renal Manifestations of ComplementMediated Thrombotic Microangiopathies, Front. Pediatr, vol.2, 2014. ,
Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures, Blood, vol.54, pp.872-876, 1979. ,
The role of properdin in the assembly of the alternative pathway C3 convertases of complement, J. Biol. Chem, vol.281, pp.2128-2132, 2006. ,
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1, Immunopharmacology, vol.49, pp.103-116, 2000. ,
, , 2007.
Defining the CD59-C9 binding interaction, J. Biol. Chem, vol.281, pp.27398-27404, 2006. ,
Generation of C5a in the absence of C3: a new complement activation pathway, Nat. Med, vol.12, pp.682-687, 2006. ,
, , 2014.
Identification of the receptor scavenging hemopexin-heme complexes, Blood, vol.106, pp.2572-2579, 2005. ,
, , 2014.
Complement receptor is an inhibitor of the complement cascade, J. Exp. Med, vol.153, pp.1138-1150, 1981. ,
, , 1987.
C5a induces tissue factor activity on endothelial cells, Thromb. Haemost, vol.77, pp.394-398, 1997. ,
Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress. Free Radic, Biol. Med, vol.108, pp.452-464, 2017. ,
, , 1981.
, Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry (Mosc.), vol.20, pp.4458-4467
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man, J. Clin. Invest, vol.58, pp.942-949, 1976. ,
, , 1999.
Prooxidant and cytotoxic effects of circulating heme, Blood, vol.100, pp.879-887, 2002. ,
Synthesis and Surface Expression of CD14 by Human Endothelial Cells, Infect. Immun, vol.69, pp.479-485, 2001. ,
Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.7971-7975, 1997. ,
, , 2003.
Human Umbilical Vein Endothelial Cells Synthesize Functional C3, C5, C6, C8 and C9 In Vitro, Scand. J. Immunol, vol.33, pp.667-671, 1991. ,
HUS and atypical HUS, Blood, vol.129, pp.2847-2856, 2017. ,
, Chem, vol.275, pp.27657-27662, 2000.
, , 1993.
Complement and complement components in acquired hemolytic anemia with high titer cold antibodies, Acta Med. Scand, vol.170, pp.725-729, 1961. ,
,
, Structural basis for therapeutic inhibition of complement C5, Nat. Struct. Mol. Biol, vol.23, pp.378-386
In vitro biosynthesis of complement factor I by human endothelial cells, Eur. J. Immunol, vol.22, pp.213-217, 1992. ,
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.2897-2902, 2011. ,
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin. Exp. Immunol, vol.21, pp.109-114, 1975. ,
, , 2017.
Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production, J. Immunol. Baltim. Md, vol.179, pp.5793-5802, 1950. ,
Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J. Immunol. Baltim. Md, vol.156, pp.4821-4832, 1950. ,
Function of soluble CD14 in serum from patients with septic shock, J. Infect. Dis, vol.173, pp.661-668, 1996. ,
Complementing the sugar code: role of GAGs and sialic acid in complement regulation, Mol. Innate Immun, vol.6, p.25, 2015. ,
Expression and function of C5a receptor in mouse microvascular endothelial cells, J. Immunol. Baltim. Md, vol.169, pp.5962-5970, 1950. ,
The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci. Publ. Protein Soc, vol.6, pp.263-274, 1997. ,
The CD46-Jagged1 interaction is critical for human TH1 immunity, Nat. Immunol, vol.13, pp.1213-1221, 2012. ,
High-resolution structures of bacterially expressed soluble human CD59, Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun, vol.63, pp.648-652, 2007. ,
, , 2010.
DNA, and histones serve as factor H ligands on the surface of apoptotic cells, J. Biol. Chem, vol.285, pp.3766-3776 ,
A brief history of G-protein coupled receptors (Nobel Lecture), Angew. Chem. Int. Ed Engl, vol.52, pp.6366-6378, 2013. ,
, , 2009.
, J. Biol. Chem, vol.284, pp.15650-15658
Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.14614-14619, 1997. ,
Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J. Immunol. Baltim. Md, vol.118, pp.815-818, 1950. ,
Meningococcal disease and the complement system, Virulence, vol.5, p.98, 2014. ,
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem. J, vol.431, pp.63-72, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00517253
Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond, Semin. Thromb. Hemost, vol.31, pp.625-632, 2005. ,
Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function, J. Clin. Pharmacol, vol.43, pp.1361-1369, 2003. ,
Platelet-associated complement factor H in healthy persons and patients with atypical HUS, Blood, vol.114, pp.4538-4545, 2009. ,
, , vol.96, pp.2784-2792, 2000.
Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability, J. Thromb. Haemost. JTH, vol.3, pp.1884-1893, 2005. ,
Role of haptoglobin in free hemoglobin metabolism, Redox Rep. Commun. Free Radic. Res, vol.6, pp.219-227, 2001. ,
Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazineinduced hemolysis, Kidney Int, vol.58, pp.1033-1044, 2000. ,
DOI : 10.1046/j.1523-1755.2000.00261.x
URL : https://doi.org/10.1046/j.1523-1755.2000.00261.x
, , 2010.
, Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll-Like Receptor Agonists and Is Blocked by Hemopexin, J. Infect. Dis, vol.202, pp.624-632
Hemopexin in severe inflammation and infection: mouse models and human diseases, Crit. Care, 2015. ,
, , 2016.
, Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia, Clin. Immunol. Orlando Fla, vol.171, pp.32-35
Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells, PloS One, vol.9, p.85934, 2014. ,
, , 1991.
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation, Immunity, vol.39, pp.1143-1157, 2013. ,
DOI : 10.1016/j.immuni.2013.10.018
URL : https://doi.org/10.1016/j.immuni.2013.10.018
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo, J. Exp. Med, vol.201, pp.567-577, 2005. ,
,
, TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation, J. Immunol. Baltim. Md, pp.857-864, 1950191.
Shiga Toxin Promotes Podocyte Injury in Experimental Hemolytic Uremic Syndrome via Activation of the Alternative Pathway of Complement, J. Am. Soc. Nephrol, vol.25, p.1786, 2014. ,
Anesthetic effects on the glycerol model of rhabdomyolysis-induced acute renal failure in rats, J. Am. Soc. Nephrol. JASN, vol.9, pp.305-309, 1998. ,
Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma, Science, vol.300, pp.1256-1262, 2003. ,
DOI : 10.1126/science.1082348
Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro, J. Biol. Chem, vol.291, pp.4974-4981, 2016. ,
DOI : 10.1074/jbc.m115.702506
URL : http://www.jbc.org/content/291/10/4974.full.pdf
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells, J. Clin. Invest, vol.52, pp.1129-1137, 1973. ,
An international consensus approach to the management of atypical hemolytic uremic syndrome in children, Pediatr. Nephrol. Berl. Ger, vol.31, pp.15-39, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02149335
Toll-like receptors differentially regulate GPCR kinases and arrestins in primary macrophages, Mol. Immunol, vol.45, pp.2312-2322, 2008. ,
DOI : 10.1016/j.molimm.2007.11.012
, , 2011.
, Chem, vol.286, pp.17585-17592
Decay-accelerating factor: biochemistry, molecular biology, and function, Annu. Rev. Immunol, vol.7, pp.35-58, 1989. ,
DOI : 10.1146/annurev.immunol.7.1.35
, , 2004.
, J. Pharmacol. Exp. Ther, vol.308, pp.175-181
Effect of phenylhydrazine on red blood cell metabolism, Cell Biochem. Funct, vol.6, pp.175-182, 1988. ,
DOI : 10.1002/cbf.290060305
Glomerular lesions in patients with sickle cell disease, Medicine, vol.89, pp.18-27, 2010. ,
Phenylhydrazine-mediated induction of haem oxygenase activity in rat liver and kidney and development of hyperbilirubinaemia. Inhibition by zincprotoporphyrin, Biochem. J, vol.217, pp.409-417, 1984. ,
Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study, J. Biophys. Biochem. Cytol, vol.11, pp.571-605, 1961. ,
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J. Clin. Invest, vol.111, pp.1181-1190, 2003. ,
DOI : 10.1172/jci16651
URL : http://www.jci.org/articles/view/16651/files/pdf
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity, Eur. J. Immunol, vol.33, pp.3367-3376, 2003. ,
DOI : 10.1002/eji.200324425
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.200324425
Structure-function relations of human hemoglobins, Proc. Bayl. Univ. Med. Cent, vol.19, pp.239-245, 2006. ,
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J. Am. Soc. Nephrol. JASN, vol.25, pp.2053-2065, 2014. ,
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies, Kidney Int, vol.92, issue.5, pp.1232-1241, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01758552
, Modulation of the antitumor immune response by complement, 2008.
, Nat. Immunol, vol.9, pp.1225-1235
Complement in removal of the dead -balancing inflammation, Immunol. Rev, vol.274, pp.218-232, 2016. ,
, , 2012.
Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition, Blood, vol.94, pp.1673-1682, 1999. ,
, , 2001.
bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction, Am. J. Physiol. Cell Physiol, vol.282, pp.578-587, 2002. ,
Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages, J. Clin. Invest, vol.92, pp.2053-2059, 1993. ,
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin, Blood, vol.100, pp.3790-3796, 2002. ,
, TAK-242 (Resatorvid), a SmallMolecule Inhibitor of Toll-Like Receptor (TLR), p.4, 2011.
Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules, Mol. Pharmacol, vol.79, pp.34-41 ,
Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol. Immunol, vol.40, pp.785-793, 2004. ,
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice, Cell, vol.74, pp.541-554, 1993. ,
Endothelial gaps as sites for plasma leakage in inflammation, vol.6, pp.7-22, 1994. ,
GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies, J. Clin. Invest, vol.84, pp.92-99, 1989. ,
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine, MMWR Morb. Mortal. Wkly. Rep, vol.66, pp.734-737, 2017. ,
Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, 2005. ,
, J. Immunol. Baltim. Md, vol.174, pp.6250-6256, 1950.
The complement factor H-related proteins, Immunol. Rev, vol.274, pp.191-201, 2016. ,
Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis, J. Biomark, vol.2015, pp.1-13, 2015. ,
,
, 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers, Immunology, vol.18, pp.1-9
, , 2015.
, Complement System Part II: Role in Immunity. Front. Immunol, vol.6
Complement System Part I -Molecular Mechanisms of Activation and Regulation, Front. Immunol, vol.6, 2015. ,
Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding, Eur. J. Haematol, vol.51, pp.282-287, 1993. ,
Visualization of oriented hemoglobin S in individual erythrocytes by differential extinction of polarized light, Proc. Natl. Acad. Sci. U. S. A, vol.82, pp.6527-6531, 1985. ,
, , 2017.
Expression and regulation of complement receptors by human natural killer cells, Immunobiology, vol.219, pp.671-679, 2014. ,
Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin, J. Clin. Invest, vol.115, pp.3409-3417, 2005. ,
, , 1992.
Complement activation during painful crisis in sickle cell anemia, Clin. Immunol. Immunopathol, vol.76, pp.314-320, 1995. ,
, , 2003.
, FASEB J, vol.17, pp.1003-1014
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem. J, vol.264, pp.1-14, 1989. ,
Terminal complexes of the complement system: new structural insights and their relevance to function, Immunol. Rev, vol.274, pp.141-151, 2016. ,
Structural basis for engagement by complement factor H of C3b on a self surface, Nat. Struct. Mol. Biol, vol.18, pp.463-470, 2011. ,
Structural Analysis of the C-Terminal Region (Modules 18-20) of Complement Regulator Factor H (FH), PLoS ONE, vol.7, 2012. ,
Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis, J. Immunol, vol.187, pp.172-180, 2011. ,
, , 1993.
An alternative mechanism for the properdin system, J. Exp. Med, vol.108, pp.515-535, 1958. ,
, , 1979.
, J. Immunol. Baltim. Md, vol.123, pp.1245-1252, 1950.
Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells, Immunol. Res, vol.24, pp.191-199, 2001. ,
Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report, Blood Coagul. Fibrinolysis Int. J. Haemost. Thromb, vol.22, pp.443-447, 2011. ,
The tick-over theory revisited: is C3 a contact-activated protein?, Immunobiology, vol.217, pp.1106-1110, 2012. ,
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT, J. Exp. Med, vol.122, pp.277-298, 1965. ,
,
Complement factor I in health and disease, Mol. Immunol, vol.48, pp.1611-1620, 2011. ,
Structural transitions of complement component C3 and its activation products, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.19737-19742, 2006. ,
, , 2006.
, Von Willebrand factor regulates complement on endothelial cells. Kidney Int, 2016.
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015, Am. J. Kidney Dis, vol.66, pp.359-375, 2015. ,
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J. Exp. Med, vol.194, pp.781-795, 2001. ,
Quantitative analysis of hemin-induced neutrophil extracellular trap formation and effects of hydrogen peroxide on this phenomenon, Biochem. Biophys. Rep, vol.11, pp.147-153, 2017. ,
No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic, Biol. Med, vol.36, pp.685-697, 2004. ,
Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, 2012. ,
, Antioxid. Redox Signal, vol.17, pp.813-846
The history of Toll-like receptors -redefining innate immunity, Nat. Rev. Immunol, vol.13, pp.453-460, 2013. ,
, , 2006.
,
, Mol. Immunol, vol.43, pp.1624-1632
, , 1995.
rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues, J. Immunol. Baltim. Md, vol.162, pp.6510-6517, 1950. ,
, CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis, vol.377, pp.52-61, 2017.
G-protein-coupled receptor kinases in inflammation and disease, Genes Immun, vol.16, pp.367-377, 2015. ,
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J. Immunol. Baltim. Md, vol.180, pp.2329-2338, 1950. ,
Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J. Mol. Biol, vol.408, pp.277-290, 2011. ,
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, vol.327, pp.524-526, 1987. ,
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria, Nat. Med, vol.13, pp.703-710, 2007. ,
Analysis of the natural polymeric forms of human properdin and their functions in complement activation, J. Immunol. Baltim. Md, vol.142, pp.202-207, 1950. ,
Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I, Biochemistry (Mosc.), vol.22, pp.178-185, 1983. ,
, , 1986.
Structure and function of complement C5 convertase enzymes, Biochem. Soc. Trans, vol.30, pp.1006-1010, 2002. ,
Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution, J. Exp. Med, vol.146, pp.257-270, 1977. ,
, , 1981.
, J. Exp. Med, vol.154, pp.856-867
, , 1983.
, Immunol. Baltim. Md, vol.131, pp.1930-1935, 1950.
, , 1991.
, , 2015.
, Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement: Medicine (Baltimore) 94, e1000
Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients, Am. J. Med, vol.59, pp.650-659, 1975. ,
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex, Nature, vol.458, pp.1191-1195, 2009. ,
Permeability of the erythrocyte for glycerol, J. Cell. Comp. Physiol, vol.6, pp.129-135, 1935. ,
, Stress erythropoiesis: new signals and new stress progenitor cells, vol.18, pp.139-145, 2011.
Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy, Science, vol.294, pp.2368-2371, 2001. ,
, , 2007.
Disease-associated Nterminal complement factor H mutations perturb cofactor and decay-accelerating activities, J. Biol. Chem, vol.286, pp.11082-11090, 2011. ,
Functional and structural insight into properdin control of complement alternative pathway amplification, EMBO J, vol.36, pp.1084-1099, 2017. ,
Blood platelets activate the classical pathway of human complement, J. Thromb. Haemost. JTH, vol.4, pp.2035-2042, 2006. ,
, , 2006.
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction, Blood, vol.111, pp.2452-2461, 2008. ,
, , 2002.
Complement factor H-ligand interactions: self-association, multivalency and dissociation constants, Immunobiology, vol.217, pp.281-297, 2012. ,
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands, Front. Immunol, vol.5, p.126, 2014. ,
Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens, PLoS Pathog, vol.6, p.1001122, 2010. ,
, Immunol. Baltim. Md, vol.151, pp.5062-5072, 1950.
Update on massive transfusion, Br. J. Anaesth, vol.111, pp.71-82, 2013. ,
DOI : 10.1093/bja/aet376
Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture, J. Clin. Invest, vol.96, pp.1145-1151, 1995. ,
, , 2011.
Systemic lupus erythematosus, complement deficiency, and apoptosis, Adv. Immunol, vol.76, pp.227-324, 2000. ,
DOI : 10.1016/s0065-2776(01)76021-x
, , 2002.
, Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H, Nat. Genet, vol.31, pp.424-428
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates, The Lancet, vol.381, pp.142-151, 2013. ,
Global Burden of Sickle Cell Anaemia in Children under Five, Modelling Based on Demographics, Excess Mortality, and Interventions, vol.10, 2010. ,
, Analysis of Factor D Isoforms in Malpuech-Michels-Mingarelli-Carnevale, 2017.
, Immunol, vol.199, pp.2158-2170
The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science, vol.120, pp.279-285, 1954. ,
, , 1994.
, J. Med, vol.330, pp.1639-1644
Evolving functions of endothelial cells in inflammation, Nat. Rev. Immunol, vol.7, pp.803-815, 2007. ,
Molecular composition of the tubular structure of the membrane attack complex of complement, J. Biol. Chem, vol.259, pp.8641-8647, 1984. ,
P-Selectin-Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell Disease, Arterioscler. Thromb. Vasc. Biol, vol.30, pp.2392-2399, 2010. ,
Human platelet activation by C3a and C3a des-arg, J. Exp. Med, vol.158, pp.603-615, 1983. ,
DOI : 10.1084/jem.158.2.603
URL : http://jem.rupress.org/content/158/2/603.full.pdf
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998. ,
Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors, J. Biol. Chem, vol.282, pp.24430-24436, 2007. ,
Heme oxygenase 1 is required for mammalian iron reutilization, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.10919-10924, 1997. ,
SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules, Eur. J. Immunol, vol.19, pp.69-75, 1989. ,
, , 1985.
, J. Immunol. Baltim. Md, vol.135, pp.445-451, 1950.
Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia, J. Pediatr. Hematol. Oncol, vol.33, pp.74-78, 2011. ,
Lipopolysaccharide endotoxins, Annu. Rev. Biochem, vol.71, pp.635-700, 2002. ,
, complement. Mol. Immunol, vol.47, pp.2505-2514, 2010.
Antigen presentation by monocytes and monocytederived cells, Curr. Opin. Immunol, vol.20, pp.52-60, 2008. ,
Über Pyrodin, Arb Ad Erst Med Klin Zu Berl ii, p.471, 1891. ,
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor, Nature, vol.450, pp.383-387, 2007. ,
The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status, Blood, vol.123, pp.121-125, 2014. ,
Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6, Clin. Exp. Immunol, vol.83, pp.488-491, 1991. ,
Occurrence of oxidatively modified proteins: an early event in experimental acute pancreatitis. Free Radic, Biol. Med, vol.24, pp.393-400, 1998. ,
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy, Curr. Opin. Hematol, vol.10, pp.99-107, 2003. ,
,
, Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease, Nat. Med, vol.8, pp.1383-1389
The platelet release reaction: granules' constituents, secretion and functions, Platelets, vol.12, pp.261-273, 2001. ,
,
, J. Exp. Med, vol.168, pp.1917-1922
, , 2012.
Azurophilic granules of human neutrophils contain CD14, Infect. Immun, vol.65, pp.4747-4753, 1997. ,
A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J. Biol. Chem, vol.290, issue.4, pp.2334-2350, 2015. ,
The structure and function of Gprotein-coupled receptors, Nature, vol.459, pp.356-363, 2009. ,
CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clin. Exp. Immunol, vol.92, pp.181-184, 1993. ,
, , 1982.
, Immunol. Baltim. Md, vol.129, pp.2051-2060, 1950.
, , 2004.
, Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran
Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers, Innate Immun, vol.14, pp.383-394, 2008. ,
, , 2009.
, The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease, vol.293, p.1653, 2005.
, , 2007.
, Nat. Biotechnol, vol.25, pp.1256-1264
Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim. Biophys. Acta, vol.1784, pp.1271-1276, 2008. ,
, , vol.114, pp.2837-2845, 2009.
Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance, J. Immunol. Baltim. Md, vol.187, pp.4369-4373, 1950. ,
Heme interacts with c1q and inhibits the classical complement pathway, J. Biol. Chem, vol.286, pp.16459-16469, 2011. ,
, , 2011.
, , 2012.
Heme: Modulator of Plasma Systems in Hemolytic Diseases, Trends Mol. Med, vol.22, pp.200-213, 2016. ,
Endothelial cells: source, barrier, and target of defensive mediators, Immunol. Rev, vol.274, pp.307-329, 2016. ,
Structural basis for complement factor I control and its diseaseassociated sequence polymorphisms, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.12839-12844, 2011. ,
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies, Thromb. Haemost, vol.93, issue.3, pp.443-452, 2005. ,
Sublytic complement attack induces cell cycle in oligodendrocytes, J. Immunol. Baltim. Md, vol.156, pp.4892-4900, 1950. ,
, , 2001.
CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma, Arch. Immunol. Ther. Exp. (Warsz.), vol.51, pp.421-428, 2003. ,
Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance, Mol. Cell. Biochem, pp.249-263, 2002. ,
Complement-mediated regulation of tissue factor activity in endothelium, J. Exp. Med, vol.182, pp.1807-1814, 1995. ,
Erythrocyte-derived ectosomes have immunosuppressive properties, J. Leukoc. Biol, vol.84, pp.1316-1325, 2008. ,
Biochemistry and genetics of von Willebrand factor, Annu. Rev. Biochem, vol.67, pp.395-424, 1998. ,
, , 2013.
G(i)-and JNK, J. Immunol. Baltim. Md, vol.175, pp.2994-2999, 1950. ,
Python: a programming language for software integration and development, J. Mol. Graph. Model, vol.17, pp.57-61, 1999. ,
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia, Br. J. Haematol, vol.164, pp.729-739, 2014. ,
, , 2012.
, J. Immunol. Baltim. Md, vol.188, pp.2030-2037, 1950.
How hemolysis causes acute pancreatitis, Med. Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.8, pp.51-52, 2002. ,
An experimental model of hemolysis-induced acute pancreatitis. Braz, J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol, vol.36, pp.879-886, 2003. ,
The role of heme in hemolysis-induced acute pancreatitis, Med. Sci. Monit. Int, 2007. ,
, Clin. Res, vol.13, pp.67-72
Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases. Front, 2013. ,
, , 2003.
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, vol.121, pp.1276-1284, 2013. ,
Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development, Oxid. Physiol, vol.5, p.415, 2014. ,
Complement Activation in a Murine Model of Sickle Cell Disease: Inhibition of VasoOcclusion By Blocking C5 Activation, Blood Journal, vol.128, p.158, 2016. ,
, , 2014.
, Structural and functional characterization of human and murine C5a anaphylatoxins, Acta Crystallogr
, D Biol. Crystallogr, vol.70, pp.1704-1717
, , 2016.
, Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway, J. Immunol. Baltim. Md, pp.337-344, 1950197.
A new map of glycosaminoglycan and C3b binding sites on factor H, J. Immunol. Baltim. Md, vol.181, pp.2610-2619, 1950. ,
Protection of host cells by complement regulators, Immunol. Rev, vol.274, pp.152-171, 2016. ,
, , 2010.
Sickle cell disease; a general overview, Neth. J. Med, vol.62, pp.364-374, 2004. ,
Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-2369, 2015. ,
Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells, J. Immunol, vol.169, pp.2102-2110, 2002. ,
In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes, J. Biol. Chem, vol.260, pp.5131-5138, 1985. ,
, , 2001.
Structure and function of lipopolysaccharide binding protein, Science, vol.249, pp.1429-1431, 1990. ,
Expression of properdin in human monocytes, Eur. J. Biochem. FEBS, vol.219, pp.759-764, 1994. ,
, , 1989.
Leukotriene B4 amplifies NF-?B activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression, J. Clin. Invest, vol.121, pp.671-682, 2011. ,
The Natural History of Sickle Cell Disease. Cold Spring Harb, 2013. ,
Membranoproliferative glomerulonephritis--a new look at an old entity, N. Engl. J. Med, vol.366, pp.1119-1131, 2012. ,
Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia, J. Thromb. Haemost. JTH, vol.6, pp.2202-2209, 2008. ,
Heterogeneous MAC Initiator and Pore Structures in a Lipid Bilayer by Phase-Plate Cryo-electron Tomography, Cell Rep, vol.15, pp.1-8, 2016. ,
,
, phospholipids. Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.13757-13762
, , 1990.
, Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms, Int. Immunol, vol.2, pp.1133-1141
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4, J. Exp. Med, vol.189, pp.1777-1782, 1999. ,
Soluble CD14 is a nonspecific marker of monocyte activation, AIDS, vol.29, pp.1263-1265, 2015. ,
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors, Proc. Natl. Acad. Sci. U. S. A, vol.91, pp.1214-1218, 1994. ,
Induction of cellular procoagulant activity by the membrane attack complex of complement, Semin. Cell Biol, vol.6, pp.275-282, 1995. ,
, , 1988.
, J. Biol. Chem, vol.263, pp.18205-18212
, , 2007.
Blocking P-selectin protects from ischemia/reperfusioninduced acute renal failure, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.14, pp.48-54, 2000. ,
Animal models of acute renal failure, Pharmacol. Rep. PR, vol.64, pp.31-44, 2012. ,
, , 2014.
, J. Immunol. Baltim. Md, pp.2857-2864, 1950192.
Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein, Biochem. J, vol.182, pp.47-54, 1979. ,
, , 2017.
, Immunol. Baltim. Md, vol.163, pp.6132-6138, 1950.
Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat. Med, vol.4, pp.1073-1077, 1998. ,
The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells, Invest. Ophthalmol. Vis. Sci, vol.42, pp.2867-2877, 2001. ,
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4, J. Invest. Dermatol, vol.119, pp.424-432, 2002. ,
Excess of heme induces tissue factordependent activation of coagulation in mice, Haematologica, vol.100, pp.308-314, 2015. ,
Polycythemia vera: myths, mechanisms, and management, Blood, vol.100, pp.4272-4290, 2002. ,
Integrin inside-out signaling and the immunological synapse, 2012. ,
, Curr. Opin. Cell Biol, vol.24, pp.107-115
Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide, Infect. Immun, vol.72, pp.3344-3349, 2004. ,
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells, Immunity, vol.28, pp.425-435, 2008. ,
, J. Med, vol.58, pp.382-387, 1975.
The excess burden of stroke in hospitalized adults with sickle cell disease, Am. J. Hematol, vol.84, pp.548-552, 2009. ,
, Semi, 2005.
URL : https://hal.archives-ouvertes.fr/in2p3-00435397
, , 2011.
, Biomarkers for early detection of sickle nephropathy, Am. J. Hematol, vol.86, pp.559-566
, , pp.1891-1899, 199382.
Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice, J. Exp. Med, vol.184, pp.2385-2392, 1996. ,
Structure of complement receptor 2 in complex with its C3d ligand, Science, vol.292, pp.1725-1728, 2001. ,
,
, A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, J. Immunol. Baltim. Md, vol.156, pp.3455-3460, 1950.
, Pharmacol, vol.157, pp.1250-1262, 2009.
The structures of deoxy human haemoglobin and the mutant Hb Tyralpha42His at 120 K, Acta Crystallogr. D Biol. Crystallogr, vol.56, pp.805-811, 2000. ,
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity, J. Exp. Med, vol.185, pp.1619-1627, 1997. ,
Molecular basis of reduced potency of underacylated endotoxins, J. Immunol. Baltim. Md, vol.175, pp.4669-4676, 1950. ,
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use, Blood, vol.125, pp.2656-2664, 2015. ,
Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J. Biol. Chem, vol.287, pp.42620-42633, 2012. ,
, , 1994.
Hemin Preconditioning Upregulates Heme Oxygenase-1 in Deceased Donor Renal Transplant Recipients: A Randomized, Controlled, Phase IIB Trial, Transplantation, vol.100, pp.176-183, 2016. ,
Hemopexin Therapy Improves Cardiovascular Function by Preventing HemeInduced Endothelial Toxicity in Mouse Models of Hemolytic Diseases, Circulation, vol.127, pp.1317-1329, 2013. ,
, , vol.12, pp.1317-1329, 2016.
MD-2 binds to bacterial lipopolysaccharide, J. Biol. Chem, vol.276, pp.38044-38051, 2001. ,
Coronary constrictor effect of stroma-free hemoglobin solutions, Am. J. Physiol, vol.251, pp.413-420, 1986. ,
VSIG4, a B7 family-related protein, is a negative regulator of T cell activation, J. Clin. Invest, vol.116, pp.2817-2826, 2006. ,
A new function of the activated third component of complement: binding to C5, an essential step for C5 activation, Immunology, vol.34, pp.29-40, 1978. ,
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells, Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. N. Y. N, vol.216, pp.456-463, 1997. ,
Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts, Kidney Int, vol.63, pp.1564-1573, 2003. ,
Paths reunited: Initiation of the classical and lectin pathways of complement activation, Immunobiology, vol.215, pp.1-11, 2010. ,
The pathophysiology, prevention, and treatment of stroke in sickle cell disease, 2007. ,
, Curr. Opin. Hematol, vol.14, pp.191-197
, , 1993.
, J. Clin. Invest, vol.92, pp.1326-1335
Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression, Cancer Discov, vol.6, pp.1022-1035, 2016. ,
,
, Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation, J. Immunol. Baltim. Md, pp.2349-2356, 1950192.
, , 1987.
, , 1976.
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011. ,
Modulation of the alternative complement pathways by beta 1 H globulin, J. Exp. Med, vol.144, pp.1147-1163, 1976. ,
, , 2011.
, Biol. Chem, vol.286, pp.20952-20962
Inhibition of cell proliferation by glycerol, Life Sci, vol.48, pp.1511-1517, 1991. ,
, , 1986.
, Biol. Chem, vol.262, pp.13674-13681, 1987.
Structure of C3b in complex with CRIg gives insights into regulation of complement activation, Nature, vol.444, pp.217-220, 2006. ,
, , 2005.
Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J. Immunol. Baltim. Md, vol.158, pp.4444-4451, 1950. ,
Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution, J. Mol. Biol, vol.98, pp.179-194, 1975. ,
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils, Blood, vol.100, pp.517-523, 2002. ,
, , 1980.
Complement therapy in atypical haemolytic uraemic syndrome (aHUS), Mol. Immunol, vol.56, pp.199-212, 2013. ,
, , 1989.
Complement inhibitors to treat IgM-mediated autoimmune hemolysis, Haematologica, vol.100, pp.1388-1395, 2015. ,
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, vol.249, pp.1431-1433, 1990. ,
, , 2016.
Structure of C3b-factor H and implications for host protection by complement regulators, Nat. Immunol, vol.10, pp.728-733, 2009. ,
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization, Proc. Natl. Acad. Sci. U. S. A, vol.110, pp.9439-9444, 2013. ,
Macrophage biology in development, homeostasis and disease, Nature, vol.496, pp.445-455, 2013. ,
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses, Nat. Struct. Mol. Biol, vol.24, pp.643-651, 2017. ,
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases, Biomark. Res, vol.2, p.1, 2014. ,
Expression of complement components and inhibitors on platelet microparticles, Platelets, vol.19, pp.225-233, 2008. ,
, , 2008.
Alpha-1-microglobulin: an indicator protein for renal tubular function, J. Clin. Pathol, vol.36, pp.253-259, 1983. ,
Treatment of autoimmune hemolytic anemias, Haematologica, vol.99, pp.1547-1554, 2014. ,
,
, CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor, vol.4, pp.868-880
Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement, Arterioscler. Thromb. Vasc. Biol, vol.34, pp.313-320, 2014. ,
A mouse model for an erythropoietin-deficiency anemia, Dis. Model. Mech, vol.3, pp.763-772, 2010. ,
Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium, Blood, vol.112, pp.3474-3483, 2008. ,
Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol. Med. Rep, vol.10, pp.45-52, 2014. ,
, , 2013.
Haemolysis of human and sheep red blood cells in glycerol media: the effect of pH and the role of band 3, Comp. Biochem. Physiol. A. Mol. Integr. Physiol, vol.127, pp.347-353, 2000. ,
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat. Rev. Nephrol, vol.8, pp.643-657 ,
Complement: a key system for immune surveillance and homeostasis, Nat Immunol, vol.11, pp.785-97, 2010. ,
Complement -tapping into new sites and effector systems, Nat Rev Immunol, vol.14, pp.811-831, 2014. ,
Complement system part II: role in immunity, Front Immunol, vol.6, p.257, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01216398
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin Exp Immunol, vol.21, pp.109-123, 1975. ,
Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3, J Exp Med, vol.154, pp.856-67, 1981. ,
The tick-over theory revisited: is C3 a contact-activated protein?, Immunobiology, vol.217, 2012. ,
Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties, Biochemistry, vol.20, pp.4458-67, 1981. ,
Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3, Biochem J, vol.431, pp.63-72, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00517253
Structural transitions of complement component C3 and its activation products, Proc Natl Acad Sci, vol.103, pp.19737-19779, 2006. ,
A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism, J Biol Chem, vol.290, issue.4, pp.2334-50, 2014. ,
Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry, J Immunol, issue.174, pp.3469-74, 2005. ,
Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation, Biochem J, pp.429-465, 1994. ,
The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci, vol.6, pp.263-74, 1997. ,
Continual low-level activation of the classical complement pathway, J Exp Med, vol.194, pp.747-56, 2001. ,
C1q and phagocytosis: the perfect complement to a good meal, J Leukoc Biol, vol.92, pp.489-97, 2012. ,
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7, J Exp Med, vol.196, pp.1553-61, 2002. ,
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens, Proc Natl Acad Sci U S A, vol.111, pp.1503-1511, 2014. ,
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation, J Leukoc Biol, vol.97, pp.147-60, 2015. ,
Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells, J Immunol, issue.173, pp.3044-50, 2004. ,
Second of two parts, N Engl J Med, vol.344, pp.1140-1144, 2001. ,
The alternative complement pathway revisited, J Cell Mol Med, vol.12, issue.4, pp.1074-84, 2008. ,
The amplification loop of the complement pathways, Adv Immunol, vol.104, pp.115-164, 2009. ,
C1q and its growing family, Immunobiology, vol.212, pp.253-66, 2007. ,
Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q, Biochemistry, vol.44, pp.14097-109, 2005. ,
Structural and functional anatomy of the globular domain of complement protein C1q, Immunol Lett, vol.95, pp.113-141, 2004. ,
Interaction of human C1q with IgG and IgM: revisited, Biochemistry, vol.47, pp.13093-102, 2008. ,
Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction, J Immunol, issue.172, pp.4351-4359, 2004. ,
Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains, Biochemistry, vol.45, pp.4093-104, 2006. ,
Existence of different but overlapping IgG-and IgM-binding sites on the globular domain of human C1q, Biochemistry, vol.45, pp.9979-88, 2006. ,
Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim Biophys Acta, vol.1784, pp.1271-1277, 2008. ,
Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36, Infect Immun, vol.64, pp.4719-4744, 1996. ,
The human c1q globular domain: structure and recognition of non-immune self ligands, Front Immunol, vol.2, p.92, 2011. ,
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation, Eur J Immunol, vol.32, pp.1726-1762, 2002. ,
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J Immunol, issue.180, pp.2329-2367, 2008. ,
Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J Mol Biol, vol.408, pp.277-90, 2011. ,
The lectin-like activity of human C1q and its implication in DNA and apoptotic cell recognition, FEBS Lett, vol.582, pp.3111-3117, 2008. ,
Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy, Eur J Biochem, vol.270, pp.4714-4734, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-01967657
Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J Biol Chem, vol.287, pp.42620-42653, 2012. ,
Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells, J Biol Chem, vol.287, pp.33733-33777, 2012. ,
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J Exp Med, vol.194, pp.781-95, 2001. ,
Interaction of C1q with the receptor calreticulin requires a conformational change in C1q, Frontiers in Immunology | www.frontiersin.org 41, vol.59, pp.485-95, 2004. ,
Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis, J Innate Immun, vol.6, pp.426-460, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01096597
A novel human serum lectin with collagen-and fibrinogen-like domains that functions as an opsonin, J Biol Chem, vol.271, pp.2448-54, 1996. ,
Identification of the C1q-binding sites of human C1r and C1s: a refined three-dimensional model of the C1 complex of complement, J Biol Chem, vol.284, pp.19340-19348, 2009. ,
Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex, J Biol Chem, vol.285, pp.32251-63, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01967560
The two major oligomeric forms of human mannan-binding lectin: chemical characterization, carbohydrate-binding properties, and interaction with MBLassociated serine proteases, J Immunol, issue.174, pp.2870-2877, 2005. ,
A second serine protease associated with mannan-binding lectin that activates complement, Nature, vol.386, pp.506-516, 1997. ,
Structure and activation of the C1 complex of complement: unraveling the puzzle, Trends Immunol, vol.25, pp.368-73, 2004. ,
Complement is activated by IgG hexamers assembled at the cell surface, Science, vol.343, pp.1260-1263, 2014. ,
Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts, Blood, vol.101, pp.1045-52, 2003. ,
Antibody density on rat red cells determines the rate of activation of the complement component C1 ,
, Eur J Immunol, vol.15, pp.976-80, 1985.
IgGs are made for walking on bacterial and viral surfaces, Nat Commun, vol.5, p.4394, 2014. ,
Deciphering the fine details of c1 assembly and activation mechanisms: "mission impossible, Front Immunol, vol.5, p.565, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01097216
Expression of recombinant human complement C1q allows identification of the C1r/ C1s-binding sites, Proc Natl Acad Sci U S A, vol.110, pp.8650-8655, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01179709
Heme interacts with c1q and inhibits the classical complement pathway, J Biol Chem, vol.286, pp.16459-69, 2011. ,
Structural biology of C1: dissection of a complex molecular machinery, Immunol Rev, vol.180, pp.136-181, 2001. ,
Structure, function and molecular genetics of human and murine C1r, Immunobiology, vol.205, pp.365-82, 2002. ,
Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity, Mol Immunol, vol.39, pp.383-94, 2002. ,
Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism, Structure, issue.10, pp.1509-1528, 2002. ,
The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex, EMBO J, vol.21, pp.231-240, 2002. ,
X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement, J Biol Chem, vol.278, pp.32157-64, 2003. ,
Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation, Proc Natl Acad Sci U S A, vol.110, 2013. ,
Activation of the early components of the classical complement pathway under physiologic conditions, J Immunol, issue.126, pp.1769-73, 1981. ,
Toward a structure-based comprehension of the lectin pathway of complement, Mol Immunol, vol.56, pp.413-435, 2013. ,
Structural and functional overview of the lectin complement pathway: its molecular basis and physiological implication, Arch Immunol Ther Exp (Warsz), vol.61, pp.273-83, 2013. ,
M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement ,
, Scand J Immunol, vol.62, pp.462-73, 2005.
L-ficolin is a pattern recognition molecule specific for acetyl groups, J Biol Chem, vol.279, pp.47513-47522, 2004. ,
Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2, Proc Natl Acad Sci U S A, vol.109, pp.10498-503, 2012. ,
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway, Immunity, vol.15, pp.161-164, 2001. ,
The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin, PLoS One, vol.8, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00868926
Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway, J Immunol, issue.177, pp.8626-8658, 2006. ,
Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway, J Biol Chem, vol.288, pp.8922-8956, 2013. ,
Mannosebinding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway, J Immunol, issue.180, pp.6132-6140, 2008. ,
Mannosebinding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?, Biochim Biophys Acta, vol.1824, pp.253-62, 2012. ,
A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations, J Biol Chem, vol.280, pp.33435-33479, 2005. ,
Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, Proc Natl Acad Sci U S A, vol.111, pp.13445-50, 2014. ,
Structural basis for activation of the complement system by component C4 cleavage, Proc Natl Acad Sci U S A, vol.109, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02095670
MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation, Trends Mol Med, vol.14, pp.511-532, 2008. ,
C1 inhibitor, a multi-functional serine protease inhibitor, Thromb Haemost, vol.104, pp.886-93, 2010. ,
, A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement, Frontiers in Immunology | www.frontiersin.org 80. Ziccardi RJ, pp.2505-2513, 1982.
Hereditary angio-oedema, Lancet, vol.379, pp.474-81, 2012. ,
A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen, J Clin Invest, vol.93, pp.303-313, 1994. ,
Complement C1q-target proteins recognition is inhibited by electric moment effectors, J Mol Recognit, vol.20, pp.405-420, 2007. ,
The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi, J Immunol, issue.172, pp.3042-50, 2004. ,
In silico and in vitro studies on the protein-protein interactions between Brugia malayi immunomodulatory protein calreticulin and human C1q, PLoS One, vol.9, 2014. ,
MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation, J Immunol, issue.183, pp.7371-7379, 2009. ,
The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while ?2-macroglobulin is not, Mol Immunol, vol.54, pp.415-437, 2013. ,
Differential substrate and inhibitor profiles for human MASP-1 and MASP-2, Mol Immunol, vol.40, pp.921-930, 2004. ,
Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1, J Immunol, issue.184, pp.2686-92, 2010. ,
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O), J Immunol, vol.190, pp.6457-67, 2013. ,
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase, J Exp Med, vol.142, pp.856-63, 1975. ,
The role of properdin in the assembly of the alternative pathway C3 convertases of complement, J Biol Chem, vol.281, pp.2128-2160, 2006. ,
Properdin: emerging roles of a pattern-recognition molecule, Annu Rev Immunol, vol.28, pp.131-55, 2010. ,
Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease, J Biol Chem, vol.286, pp.5359-67, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00638479
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation, Blood, vol.117, pp.1340-1349, 2011. ,
Myeloperoxidase directs properdin-mediated complement activation, J Innate Immun, vol.6, pp.417-442, 2014. ,
Weibel-Palade bodies -sentinels of acute stress, Nat Rev Nephrol, vol.5, pp.423-429, 2009. ,
Platelet activation leads to activation and propagation of the complement system, J Exp Med, vol.201, pp.871-880, 2005. ,
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis, J Immunol, vol.187, 2011. ,
Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes, Blood, vol.107, pp.1192-1201, 2006. ,
Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J Immunol, issue.179, pp.5543-52, 2007. ,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-92, 2013. ,
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease, Blood, vol.123, pp.377-90, 2014. ,
Structures of C3b in complex with factors B and D give insight into complement convertase formation, Science, vol.330, pp.1816-1836, 2010. ,
Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex, EMBO J, vol.28, pp.2469-78, 2009. ,
Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase, J Immunol, issue.183, pp.7347-51, 2009. ,
Recombinant and native zymogen forms of human complement factor D, J Immunol, issue.152, pp.3645-53, 1994. ,
The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway, J Immunol, issue.187, pp.3751-3759, 2011. ,
Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D, J Exp Med, vol.207, pp.29-37, 2010. ,
C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo, Clin Exp Immunol, vol.176, pp.84-92, 2014. ,
Mannanbinding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function, J Immunol, issue.189, pp.3957-69, 2012. ,
Factor B structure provides insights into activation of the central protease of the complement system, Nat Struct Mol Biol, vol.14, pp.224-232, 2007. ,
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-728, 2009. ,
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb), Mol Immunol, vol.45, pp.2370-2379, 2008. ,
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation, Acta Crystallogr D Biol Crystallogr, vol.65, pp.266-74, 2009. ,
Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency, Immunol, vol.56, pp.561-70, 1985. ,
Bradykinin and the pathogenesis of hereditary angioedema, World Allergy Organ J, vol.4, issue.4, pp.73-78, 2011. ,
Complement driven by conformational changes, Nat Rev Immunol, vol.8, pp.48-58, 2008. ,
The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase, Biochem J, vol.235, pp.723-753, 1986. ,
Properdin and factor h: opposing players on the alternative complement pathway "see-saw, Front Immunol, vol.4, p.93, 2013. ,
Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells, J Immunol, issue.151, pp.2521-2529, 1993. ,
Expression of properdin in human monocytes, Eur J Biochem, vol.219, pp.759-64, 1994. ,
Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils, J Immunol, issue.158, pp.4444-51, 1997. ,
Properdin plays a protective role in polymicrobial septic peritonitis, J Immunol, issue.180, pp.3313-3321, 2008. ,
Semiextended solution structure of human myeloma immunoglobulin D determined by constrained X-ray scattering, J Mol Biol, vol.353, pp.155-73, 2005. ,
Analysis of the natural polymeric forms of human properdin and their functions in complement activation, J Immunol, issue.142, pp.202-209, 1989. ,
Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement, Front Immunol, vol.3, p.412, 2012. ,
Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement, Immunobiology, vol.215, pp.932-972, 2010. ,
Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin, Proc Natl Acad Sci U S A, vol.110, pp.13504-13513, 2013. ,
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement, Proc Natl Acad Sci U S A, vol.108, pp.2897-902, 2011. ,
Structural basis for engagement by complement factor H of C3b on a self surface, Nat Struct Mol Biol, vol.18, 2011. ,
Structure of C3b-factor H and implications for host protection by complement regulators, Nat Immunol, vol.10, pp.728-761, 2009. ,
Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component, J Immunol, issue.156, pp.4821-4853, 1996. ,
Structural basis for complement factor I control and its disease-associated sequence polymorphisms, Proc Natl Acad Sci U S A, vol.108, pp.12839-12883, 2011. ,
Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g, J Immunol, issue.132, pp.1960-1966, 1984. ,
A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1, Ann Hum Genet, vol.49, pp.31-40, 1985. ,
Membrane cofactor protein: importance of N-and O-glycosylation for complement regulatory function, J Immunol, issue.161, pp.3711-3719, 1998. ,
Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells, J Immunol, issue.168, pp.6298-304, 2002. ,
Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster, Annu Rev Immunol, vol.9, pp.431-55, 1991. ,
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens, PLoS Pathog, vol.6, 2010. ,
Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46), J Biol Chem, vol.275, pp.37692-701, 2000. ,
Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-69, 2015. ,
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis, J Exp Med, vol.168, pp.1699-717, 1988. ,
Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele, J Exp Med, vol.169, pp.847-63, 1989. ,
Structure-function analysis of the active sites of complement receptor type 1, J Biol Chem, vol.273, pp.8623-8632, 1998. ,
Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor, Cell, vol.108, pp.769-80, 2002. ,
Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35), J Biol Chem, vol.274, pp.5120-5150, 1999. ,
A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function, J Biol Chem, vol.274, pp.19237-19282, 1999. ,
Structural requirements for the complement regulatory activities of C4BP, J Biol Chem, vol.276, pp.27136-27180, 2001. ,
Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function, J Biol Chem, vol.278, pp.43437-43479, 2003. ,
Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP), Mol Immunol, vol.46, pp.2902-2912, 2009. ,
Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein, J Mol Biol, vol.425, pp.1302-1319, 2013. ,
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein, Biochemistry, vol.41, pp.9349-57, 2002. ,
Characterization of the interaction of human C4b-binding protein with physiological ligands, J Biol Chem, vol.259, pp.13674-13683, 1984. ,
Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b, Proc Natl Acad Sci U S A, vol.80, pp.3461-3466, 1983. ,
Thrombomodulin mutations in atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.345-57, 2009. ,
The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status, Blood, vol.123, pp.121-126, 2014. ,
Afshar-Kharghan V. Von Willebrand Factor is a cofactor in complement regulation, Blood, vol.125, issue.6, pp.1034-1041, 2014. ,
Decay accelerating activity of complement receptor Frontiers in Immunology | www.frontiersin.org type 1 (CD35). Two active sites are required for dissociating C5 convertases, J Biol Chem, vol.274, pp.31160-31168, 1999. ,
Structure and function of decay accelerating factor CD55, J Lab Clin Med, vol.123, pp.485-91, 1994. ,
Decayaccelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb, J Biol Chem, vol.277, pp.1107-1119, 2002. ,
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55), J Biol Chem, vol.280, pp.2569-78, 2005. ,
Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay, J Immunol, vol.178, pp.352-361, 2007. ,
Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation, Infect Immun, vol.70, pp.4485-93, 2002. ,
Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b, J Immunol, issue.122, pp.75-81, 1979. ,
Control of the amplification convertase of complement by the plasma protein beta1H, Proc Natl Acad Sci U S A, vol.73, pp.3268-72, 1976. ,
Modulation of the alternative complement pathways by beta 1 H globulin, J Exp Med, vol.144, pp.1147-63, 1976. ,
Complement factor H-ligand interactions: self-association, multivalency and dissociation constants, Immunobiology, vol.217, pp.281-97, 2012. ,
FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function, Immunol Today, vol.20, 1999. ,
Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H, J Immunol, issue.169, pp.6935-6979, 2002. ,
Each of the three binding sites on complement factor H interacts with a distinct site on C3b, J Biol Chem, vol.275, pp.27657-62, 2000. ,
Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH), PLoS One, vol.7, issue.2, p.32187, 2012. ,
Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d, Mol Immunol, vol.47, pp.1686-91, 2010. ,
Structural basis for sialic acid-mediated self-recognition by complement factor H, Nat Chem Biol, vol.11, issue.1, pp.77-82, 2014. ,
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, issue.182, pp.7009-7027, 2009. ,
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome, EMBO J, vol.25, pp.1784-94, 2006. ,
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome, J Biol Chem, vol.284, pp.15650-15658, 2009. ,
Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation, J Mol Biol, vol.391, pp.119-154, 2009. ,
The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein, Clin Exp Immunol, vol.144, pp.342-52, 2006. ,
Structural basis for complement factor H linked age-related macular degeneration, J Exp Med, vol.204, pp.2277-83, 2007. ,
The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module, J Mol Biol, vol.395, pp.105-127, 2010. ,
Solution structure of CCP modules 10-12 illuminates functional architecture of the complement regulator, factor H, J Mol Biol, vol.424, pp.295-312, 2012. ,
A new map of glycosaminoglycan and C3b binding sites on factor H, J Immunol, issue.181, pp.2610-2619, 2008. ,
Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis, Proc Natl Acad Sci U S A, vol.93, pp.10996-1001, 1996. ,
Identification of the second heparin-binding domain in human complement factor H, J Immunol, issue.160, pp.3342-3350, 1998. ,
The proteoglycan glycomatrix: a sugar microenvironment essential for complement regulation, Inflammation, vol.4, p.412, 2013. ,
Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism, J Biol Chem, vol.282, pp.18960-18968, 2007. ,
Localization of the third heparin-binding site in the human complement regulator factor H1, Mol Immunol, vol.43, pp.1624-1656, 2006. ,
Molecular interactions between complement factor H and its heparin and heparan sulfate ligands, Front Immunol, vol.5, p.126, 2014. ,
Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate, J Biol Chem, vol.287, pp.31471-81, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00847974
Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS), Methods Mol Biol, vol.1100, pp.237-284, 2014. ,
Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions, J Immunol, pp.2049-57, 0190. ,
Complementing the sugar code: role of GAGs and sialic acid in complement regulation, Mol Innate Immun, vol.6, p.25, 2015. ,
Complement factor H polymorphism and age-related macular degeneration, Science, vol.308, pp.421-425, 2005. ,
A common haplotype in the complement regulatory gene factor H (HF1/ CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, vol.102, pp.7227-7259, 2005. ,
Complement factor H variant increases the risk of age-related macular degeneration, Science, vol.308, pp.419-440, 2005. ,
Complement factor H polymorphism in age-related macular degeneration, Science, vol.308, pp.385-394, 2005. ,
Complement factor H genotypes impact risk of age-related macular degeneration by interaction Frontiers in Immunology | www.frontiersin.org with oxidized phospholipids, Proc Natl Acad Sci U S A, vol.109, pp.13757-62, 2012. ,
The innate immune response to products of phospholipid peroxidation, Biochim Biophys Acta, vol.1818, pp.2465-75, 2012. ,
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011. ,
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations, J Biol Chem, vol.285, pp.1053-65, 2010. ,
Complement factor H related proteins (CFHRs), Mol Immunol, vol.56, 2013. ,
Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, vol.110, pp.4685-90, 2013. ,
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J Clin Invest, vol.123, pp.2434-2480, 2013. ,
An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD), Hum Mol Genet, vol.19, pp.4694-704, 2010. ,
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation, Blood, vol.114, pp.2439-2486, 2009. ,
The making of a macromolecular machine: assembly of the membrane attack complex, Biochemistry, vol.53, pp.1908-1923, 2014. ,
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, issue.141, pp.3895-901, 1988. ,
Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation, J Biol Chem, vol.267, pp.4171-4177, 1992. ,
Formation of covalently linked C3-C3 dimers on IgG immune aggregates, Eur J Immunol, vol.21, pp.343-352, 1991. ,
Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex, EMBO J, vol.30, pp.606-622, 2011. ,
Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement, J Immunol, vol.194, pp.5488-96, 2015. ,
Structure and function of complement C5 convertase enzymes, Biochem Soc Trans, vol.30, pp.1006-1016, 2002. ,
Formation of high affinity C5 convertase of the classical pathway of complement, J Biol Chem, vol.278, pp.38476-83, 2003. ,
Surface-dependent modulation by H of C5 cleavage by the cell-bound alternative pathway C5 convertase of human complement, J Immunol, issue.130, pp.2821-2825, 1983. ,
A molecular concept of the properdin pathway, Proc Natl Acad Sci U S A, vol.73, pp.612-618, 1976. ,
Generation of C5a in the absence of C3: a new complement activation pathway, Nat Med, vol.12, pp.682-689, 2006. ,
Molecular intercommunication between the complement and coagulation systems, J Immunol, issue.185, pp.5628-5664, 2010. ,
Generation of C5a by phagocytic cells, Am J Pathol, vol.161, issue.10, pp.64461-64467, 2002. ,
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway, Blood, vol.120, pp.1717-1742, 2012. ,
Interaction between the coagulation and complement system, Adv Exp Med Biol, vol.632, pp.71-80, 2008. ,
Plasminogen is a complement inhibitor, J Biol Chem, vol.287, pp.18831-18873, 2012. ,
Interplay between fibrinolysis and complement: plasmin cleavage of iC3b modulates immune responses, J Thromb Haemost, vol.13, issue.4, pp.610-618, 2014. ,
Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9, Cell Rep, vol.1, pp.200-207, 2012. ,
The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7, J Immunol, issue.135, pp.445-51, 1985. ,
Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense, Science, vol.317, pp.1552-1556, 2007. ,
Complement lysis: a hole is a hole, Immunol Today, vol.12, p.90007, 1991. ,
Beyond lysis: how complement influences cell fate, Clin Sci, vol.1979, issue.104, pp.455-66, 2003. ,
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics, Proc Natl Acad Sci U S A, vol.80, pp.3816-3836, 1983. ,
Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect Immun, vol.55, pp.206-216, 1987. ,
Meningococcal disease and the complement system, Virulence, vol.5, pp.98-126, 2014. ,
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem J, vol.264, pp.1-14, 1989. ,
Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region, Biochem J, vol.195, pp.15-30, 1981. ,
The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium, Biochem J, vol.231, pp.205-213, 1985. ,
Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence, J Immunol, issue.123, pp.1245-52, 1979. ,
A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes, Mol Immunol, vol.26, pp.90139-90148, 1989. ,
SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules, Eur J Immunol, vol.19, pp.69-75, 1989. ,
Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9, J Immunol, issue.151, pp.2159-65, 1993. ,
Structure of a soluble, glycosylated form of the human complement regulatory protein CD59, Structure, vol.1993, issue.2, pp.185-99, 1994. ,
High-resolution structures of bacterially expressed soluble human CD59, Acta Crystallogr Sect F Struct Biol Cryst Commun, vol.63, pp.648-52, 2007. ,
CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by Frontiers in Immunology | www.frontiersin.org homologous C5b-8 as well as C5b-9, J Physiol, vol.539, pp.537-582, 2002. ,
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers, Immunology, vol.71, pp.1-9, 1990. ,
Defining the CD59-C9 binding interaction, J Biol Chem, vol.281, pp.27398-404, 2006. ,
Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement, J Biol Chem, vol.286, pp.17585-92, 2011. ,
Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9, J Biol Chem, vol.286, pp.20952-62, 2011. ,
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex, J Immunol, issue.173, pp.6921-6928, 2004. ,
Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis, J Immunol, issue.138, pp.246-53, 1987. ,
Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex, J Biol Chem, vol.282, pp.29977-86, 2007. ,
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement, Nature, vol.339, pp.620-622, 1989. ,
The role of the anaphylatoxins in health and disease, Mol Immunol, vol.46, pp.2753-66, 2009. ,
Chemotaxis by mouse macrophage cell lines, J Immunol, issue.126, pp.2194-2203, 1981. ,
Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages, Immunology, vol.79, pp.633-641, 1993. ,
C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils, Eur J Immunol, vol.24, pp.518-540, 1994. ,
Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst, FEBS Lett, vol.346, pp.181-185, 1994. ,
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins, Blood, vol.83, pp.3324-3355, 1994. ,
Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J Immunol, pp.3542-3550, 0194. ,
Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a, Eur J Immunol, vol.23, pp.558-61, 1993. ,
Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J Immunol, issue.118, pp.815-823, 1977. ,
Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells, J Invest Dermatol, vol.102, pp.803-809, 1994. ,
Human T cells express the C5a receptor and are chemoattracted to C5a, J Immunol, issue.162, pp.4018-4041, 1999. ,
Modulation of the antitumor immune response by complement, Nat Immunol, vol.9, pp.1225-1260, 2008. ,
Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis, Am J Pathol, vol.142, pp.1848-57, 1993. ,
Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol Med Rep, vol.10, pp.45-52, 2014. ,
C4a: an anaphylatoxin in name only, J Innate Immun, 2015. ,
Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy, Proteins, vol.28, pp.261-268, 1997. ,
Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol Immunol, vol.40, pp.785-93, 2004. ,
Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock, J Immunol, issue.182, pp.6533-6542, 2009. ,
Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg, Protein Sci, vol.22, pp.204-216, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02095673
Structure of human desArg-C5a, Acta Crystallogr D Biol Crystallogr, vol.66, pp.190-197, 2010. ,
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes, Brain Res Mol Brain Res, vol.112, pp.46-55, 2003. ,
Structural and functional characterization of human and murine C5a anaphylatoxins, Acta Crystallogr D Biol Crystallogr, vol.70, pp.1704-1721, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02096131
Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin, J Biol Chem, vol.278, pp.37902-37910, 2013. ,
Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, vol.42, pp.581-588, 2005. ,
Evidence that the extracellular N-terminal domain of C5aR contains amino-acid residues crucial for C5a binding, Eur J Haematol, vol.51, pp.282-289, 1993. ,
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors, Proc Natl Acad Sci U S A, vol.91, pp.1214-1222, 1994. ,
Structure-function relationships of human C5a and C5aR, J Immunol, issue.170, pp.6115-6139, 2003. ,
An activation switch in the ligand binding pocket of the C5a receptor, J Biol Chem, vol.276, pp.3394-400, 2001. ,
A comprehensive structure-function map of the intracellular surface of the human C5a receptor. I. Identification of critical residues, J Biol Chem, vol.282, pp.3105-3126, 2007. ,
Essential role for the second extracellular loop in C5a receptor activation, Nat Struct Mol Biol, vol.12, pp.320-326, 2005. ,
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway, Kidney Int, vol.61, pp.456-63, 2002. ,
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK, J Immunol, issue.175, pp.2994-3003, 2005. ,
Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci U S A, vol.94, pp.7971-7976, 1997. ,
, Frontiers in Immunology | www.frontiersin.org
Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides, J Immunol, issue.144, pp.1901-1909, 1990. ,
Mapping of the C5a receptor signal transduction network in human neutrophils, Proc Natl Acad Sci U S A, vol.91, pp.9190-9194, 1994. ,
Identification of four novel human G protein-coupled receptors expressed in the brain, Brain Res Mol Brain Res, vol.86, pp.13-22, 2001. ,
, Biochemistry, vol.42, pp.9406-9421, 2003.
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74), J Biol Chem, vol.277, pp.7165-7174, 2002. ,
Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis, J Immunol, pp.4001-4010, 0191. ,
C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology, Cell Signal, vol.25, pp.910-918, 2013. ,
C5L2 is required for C5a-triggered receptor internalization and ERK signaling, Cell Signal, vol.26, pp.1409-1428, 2014. ,
beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2, J Cell Biol, vol.148, pp.1267-81, 2000. ,
Shenoy SK. ?-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007. ,
Macrophage complement receptors and pathogen clearance, Cell Microbiol, vol.9, pp.2095-102, 2007. ,
A role of macrophage complement receptor CRIg in immune clearance and inflammation, Mol Immunol, vol.45, pp.4041-4048, 2008. ,
VSIG4, a B7 family-related protein, is a negative regulator of T cell activation, J Clin Invest, vol.116, pp.2817-2843, 2006. ,
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes, J Exp Med, vol.178, pp.1407-1424, 1993. ,
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-50, 1996. ,
Regulation of humoral immunity by complement, Immunity, vol.37, pp.199-207, 2012. ,
Interaction of iC3b with recombinant isotypic and chimeric forms of CR2, J Immunol, issue.147, pp.590-594, 1991. ,
Structure of complement receptor 2 in complex with its C3d ligand, Science, vol.292, pp.1725-1733, 2001. ,
Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d, J Mol Biol, vol.346, pp.845-58, 2005. ,
Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure, J Immunol, issue.184, pp.1946-55, 2010. ,
Integrin inside-out signaling and the immunological synapse, Curr Opin Cell Biol, vol.24, pp.107-122, 2012. ,
Phagocytosis of microbes: complexity in action, Annu Rev Immunol, vol.20, pp.825-52, 2002. ,
Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3, Proc Natl Acad Sci U S A, vol.110, pp.16426-16457, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02095685
Molecular basis for complement recognition by integrin ?X?2, Proc Natl Acad Sci U S A, vol.109, pp.4586-91, 2012. ,
The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands, J Cell Biol, vol.120, pp.1031-1074, 1993. ,
Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy, Proc Natl Acad Sci U S A, vol.108, 2011. ,
An internal ligand-bound, metastable state of a leukocyte integrin, ?X?2, J Cell Biol, vol.203, pp.629-671, 2013. ,
Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages, J Immunol, issue.181, pp.7902-7910, 2008. ,
CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens, Cell, vol.124, pp.915-942, 2006. ,
Structure of C3b in complex with CRIg gives insights into regulation of complement activation, Nature, vol.444, pp.217-237, 2006. ,
Genetics of hemolytic uremic syndromes, vol.1983, pp.105-119, 2012. ,
Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.1676-87, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01793663
Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011. ,
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J Clin Invest, vol.111, pp.1181-90, 2003. ,
Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome, Am J Hum Genet, vol.71, pp.1285-95, 2002. ,
Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H, Mol Immunol, vol.41, pp.81-85, 2004. ,
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-52, 2008. ,
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-91, 2012. ,
Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-65, 2014. ,
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc Natl Acad Sci U S A, vol.104, pp.240-245, 2007. ,
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, pp.2837-2882, 2009. ,
Complement in immune and inflammatory disorders: therapeutic interventions, J Immunol, pp.3839-3886, 0190. ,
, Frontiers in Immunology | www.frontiersin.org
Physiological and therapeutic complement regulators in kidney transplantation, Curr Opin Organ Transplant, vol.18, pp.421-430, 2013. ,
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria, Nat Biotechnol, vol.25, pp.1256-64, 2007. ,
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, pp.1233-1276, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00599451
Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013. ,
Frémeaux-Bacchi V; French Study Group for aHUS/C3G . Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-57, 2012. ,
Solution structure of compstatin, a potent complement inhibitor, Protein Sci, vol.7, pp.619-646, 1998. ,
Compstatin: a complement inhibitor on its way to clinical application, Adv Exp Med Biol, vol.632, pp.273-92, 2008. ,
Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition, J Biol Chem, vol.282, pp.29241-29248, 2007. ,
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation, Blood, vol.92, pp.1661-1668, 1998. ,
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis, Blood, vol.116, pp.1002-1012, 2010. ,
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood, vol.123, pp.2094-101, 2014. ,
An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H, J Immunol, pp.912-933, 0191. ,
Rational engineering of a minimized immune inhibitor with unique triple-targeting properties, J Immunol, pp.5712-5733, 0190. ,
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases, Blood, vol.118, pp.4705-4718, 2011. ,
Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d, J Mol Biol, vol.418, pp.248-63, 2012. ,
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury, J Immunol, issue.181, pp.8068-76, 2008. ,
The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment, Blood, vol.119, pp.6307-6323, 2012. ,
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration, Adv Exp Med Biol, vol.703, pp.137-186, 2010. ,
Complement system part I -molecular mechanisms of activation and regulation, Front Immunol, vol.6, p.262, 2015. ,
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation, Clin Exp Immunol, vol.21, pp.109-123, 1975. ,
Classification of cell death: recommendations of the nomenclature committee on cell death, Cell Death Differ, vol.16, pp.3-11, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00407686
C1q and phagocytosis: the perfect complement to a good meal, J Leukoc Biol, vol.92, pp.489-97, 2012. ,
Complement: a key system for immune surveillance and homeostasis, Nat Immunol, vol.11, pp.785-97, 2010. ,
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition, J Immunol, issue.180, pp.2329-2367, 2008. ,
Investigations on the C1q-calreticulin-phosphatidylserine interactions yield new insights into apoptotic cell recognition, J Mol Biol, vol.408, pp.277-90, 2011. ,
Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein, J Biol Chem, vol.287, pp.42620-42653, 2012. ,
Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis, J Innate Immun, vol.6, pp.426-460, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01096597
C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells, J Immunol, issue.183, pp.6175-85, 2009. ,
Immune modulation of human dendritic cells by complement, Eur J Immunol, vol.37, pp.2803-2814, 2007. ,
Systemic lupus erythematosus, complement deficiency, and apoptosis, Adv Immunol, vol.76, pp.227-324, 2000. ,
Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance, J Immunol, issue.187, pp.4369-73, 2011. ,
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells, J Exp Med, vol.194, pp.781-95, 2001. ,
Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells, J Immunol, issue.188, pp.5682-93, 2012. ,
Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation, J Leukoc Biol, vol.97, pp.147-60, 2015. ,
Second of two parts, N Engl J Med, vol.344, pp.1140-1144, 2001. ,
C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells, Blood, vol.113, pp.3485-93, 2009. ,
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death, EMBO J, vol.31, pp.1062-79, 2012. ,
Extracellular matrix proteins modulate antimigratory and apoptotic effects of doxorubicin, Chemother Res Pract, p.268681, 2012. ,
iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade, Eur J Immunol, vol.40, pp.699-709, 2010. ,
Complement-dependent clearance of apoptotic cells by human macrophages, J Exp Med, vol.188, pp.2313-2333, 1998. ,
Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production, Blood, vol.101, pp.611-631, 2003. ,
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7, J Exp Med, vol.196, pp.1553-61, 2002. ,
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation, Immunity, vol.39, pp.1143-57, 2013. ,
Coupling nutrient sensing to metabolic homoeostasis: the role of the mammalian target of rapamycin complex 1 pathway, Proc Nutr Soc, vol.71, pp.502-512, 2012. ,
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells, Immunity, vol.28, pp.425-460, 2008. ,
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype, J Immunol, issue.176, pp.3330-3371, 2006. ,
mTOR signaling at a glance, J Cell Sci, vol.122, pp.3589-94, 2009. ,
Structural and functional anatomy of the globular domain of complement protein C1q, Immunol Lett, vol.95, pp.113-141, 2004. ,
Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide, Biochim Biophys Acta, vol.1784, pp.1271-1277, 2008. ,
Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36, Infect Immun, vol.64, pp.4719-4744, 1996. ,
Role of the mannose-binding lectin in innate immunity, J Infect Dis, vol.187, issue.2, pp.335-344, 2003. ,
Antibody polyreactivity in health and disease: statu variabilis, J Immunol, pp.993-1002, 0191. ,
Structure and activation of the C1 complex of complement: unraveling the puzzle, Trends Immunol, vol.25, pp.368-73, 2004. ,
, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.
Role of Ca2+ in the electrostatic stability and the functional activity of the globular domain of human C1q, Biochemistry, vol.44, pp.14097-109, 2005. ,
Toward a structure-based comprehension of the lectin pathway of complement, Mol Immunol, vol.56, pp.413-435, 2013. ,
Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes, Proc Natl Acad Sci U S A, vol.111, pp.13445-50, 2014. ,
Structural basis for activation of the complement system by component C4 cleavage, Proc Natl Acad Sci U S A, vol.109, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02095670
A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations, J Biol Chem, vol.280, pp.33435-33479, 2005. ,
C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme, J Immunol, issue.141, pp.3895-901, 1988. ,
The making of a macromolecular machine: assembly of the membrane attack complex, Biochemistry, vol.53, pp.1908-1923, 2014. ,
Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing, J Immunol, vol.130, pp.845-854, 1983. ,
Formation of transmural complement pores in serum-sensitive Escherichia coli, Infect Immun, vol.55, pp.206-216, 1987. ,
Meningococcal disease and the complement system, Virulence, vol.5, pp.98-126, 2014. ,
Beyond lysis: how complement influences cell fate, Clin Sci, issue.104, pp.455-66, 2003. ,
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects, Biochem J, vol.264, pp.1-14, 1989. ,
Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region, Biochem J, vol.195, pp.15-30, 1981. ,
The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium, Biochem J, vol.231, pp.205-213, 1985. ,
Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1) ,
, J Immunol, issue.135, pp.2680-2686, 1985.
High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis, J Immunol, issue.145, pp.697-701, 1990. ,
Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch, J Clin Invest, vol.86, pp.300-308, 1990. ,
Integrin-dependent phagocytosis: spreading from microadhesion to new concepts, J Cell Sci, vol.121, pp.1773-83, 2008. ,
Integrin CD11c/CD18 ?-chain phosphorylation is functionally important, J Biol Chem, vol.288, pp.33494-33503, 2013. ,
CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions, Clin Exp Immunol, vol.92, pp.181-185, 1993. ,
Mechanisms of phagocytosis in macrophages, Annu Rev Immunol, vol.17, pp.593-623, 1999. ,
Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages, J Immunol, issue.181, pp.7902-7910, 2008. ,
Neutrophil beta2 integrins: moderators of life or death decisions, Trends Immunol, vol.26, pp.388-95, 2005. ,
The role of the anaphylatoxins in health and disease, Mol Immunol, vol.46, pp.2753-66, 2009. ,
International union of basic and clinical pharmacology ,
Complement peptide C5a, C4a, and C3a receptors, Pharmacol Rev, vol.65, pp.500-543, 2013. ,
Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages, Immunology, vol.79, pp.633-641, 1993. ,
C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils, Eur J Immunol, vol.24, pp.518-540, 1994. ,
C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxinsensitive G-proteins, Blood, vol.83, pp.3324-3355, 1994. ,
Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a, Eur J Immunol, vol.23, pp.558-61, 1993. ,
Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells, J Invest Dermatol, vol.102, pp.803-809, 1994. ,
Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth, J Immunol, pp.3542-3550, 0194. ,
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a, Nature, vol.446, pp.203-210, 2007. ,
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation, J Exp Med, vol.181, pp.2119-2146, 1995. ,
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a, Mol Immunol, vol.45, pp.1907-1922, 2008. ,
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization, Proc Natl Acad Sci U S A, vol.110, pp.9439-9483, 2013. ,
Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis, Am J Pathol, vol.142, pp.1848-57, 1993. ,
Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury, Mol Med Rep, vol.10, pp.45-52, 2014. ,
C4a: an anaphylatoxin in name only, J Innate Immun, 2015. ,
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N, Microbiol Immunol, vol.46, pp.131-135, 2002. ,
Carboxypeptidase N: a pleiotropic regulator of inflammation, Mol Immunol, vol.40, pp.785-93, 2004. ,
Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock, J Immunol, issue.182, pp.6533-6542, 2009. ,
Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model, J Thromb Haemost, 2015. ,
Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes, Brain Res Mol Brain Res, vol.112, pp.46-55, 2003. ,
Structural and functional characterization of human and murine C5a Frontiers in Immunology | www.frontiersin.org May 2015 | Volume 6 | Article 257 anaphylatoxins, Acta Crystallogr D Biol Crystallogr, vol.70, pp.1704-1721, 2014. ,
Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells, Eur J Immunol, vol.26, pp.1944-50, 1996. ,
C3a(desArg) does not bind to and signal through the human C3a receptor, Immunol Lett, vol.67, pp.141-146, 1999. ,
Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, vol.42, pp.581-588, 2005. ,
C3a and C5a stimulate chemotaxis of human mast cells, Blood, vol.89, pp.2863-70, 1997. ,
C3a modulates IL-1? secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation, Blood, vol.122, pp.3473-81, 2013. ,
A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis, J Immunol, issue.156, pp.3455-60, 1996. ,
Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response, J Immunol, issue.159, pp.4279-86, 1997. ,
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction, Blood, vol.111, pp.2452-61, 2008. ,
Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation, Mol Immunol, vol.58, pp.98-107, 2014. ,
DOI : 10.1016/j.molimm.2013.11.010
Novel roles of complement in T effector cell regulation, Immunobiology, vol.217, pp.216-240, 2012. ,
Weibel-Palade bodies -sentinels of acute stress, Nat Rev Nephrol, vol.5, pp.423-429, 2009. ,
Biochemistry and genetics of von Willebrand factor, Annu Rev Biochem, vol.67, pp.395-424, 1998. ,
Platelet activation leads to activation and propagation of the complement system, J Exp Med, vol.201, pp.871-880, 2005. ,
Alternative pathway activation of complement by shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis, J Immunol, vol.187, 2011. ,
The chemotactic receptor for human C5a anaphylatoxin, Nature, vol.349, pp.614-621, 1991. ,
C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinasesignaling pathway, Kidney Int, vol.61, pp.456-63, 2002. ,
G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinaseprotein 3 kinase B/Akt pathway and JNK, J Immunol, issue.175, pp.2994-3003, 2005. ,
Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci U S A, vol.94, pp.7971-7976, 1997. ,
Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides, J Immunol, issue.144, pp.1901-1909, 1990. ,
Mapping of the C5a receptor signal transduction network in human neutrophils, Proc Natl Acad Sci U S A, vol.91, pp.9190-9194, 1994. ,
Chemotaxis by mouse macrophage cell lines, J Immunol, issue.126, pp.2194-2203, 1981. ,
Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst, FEBS Lett, vol.346, issue.94, pp.463-466, 1994. ,
Histamine-induced inhibition of normal human basophil chemotaxis to C5a, J Immunol, issue.118, pp.815-823, 1977. ,
Modulation of the antitumor immune response by complement, Nat Immunol, vol.9, pp.1225-1260, 2008. ,
Human T cells express the C5a receptor and are chemoattracted to C5a, J Immunol, issue.162, pp.4018-4041, 1999. ,
rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues, J Immunol, issue.162, pp.6510-6517, 1999. ,
Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production, J Immunol, issue.179, pp.5793-802, 2007. ,
Protective effects of C5a blockade in sepsis, Nat Med, vol.5, pp.788-92, 1999. ,
C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells, Curr Eye Res, vol.34, pp.57-61, 2009. ,
Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner, J Immunol, pp.3414-3435, 0194. ,
Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation, Mol Immunol, vol.46, pp.3207-3224, 2009. ,
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74), J Biol Chem, vol.277, pp.7165-7174, 2002. ,
, Biochemistry, vol.42, pp.9406-9421, 2003.
The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction, J Biol Chem, vol.285, pp.7633-7677, 2010. ,
Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis, J Immunol, pp.4001-4010, 0191. ,
An antiinflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2, J Biol Chem, vol.280, pp.39677-80, 2005. ,
High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques, Am J Pathol, vol.184, pp.2123-2156, 2014. ,
C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology, Cell Signal, vol.25, pp.910-918, 2013. ,
C5L2 is required for C5a-triggered receptor internalization and ERK signaling, Cell Signal, vol.26, pp.1409-1428, 2014. ,
betaarrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2, J Cell Biol, vol.148, pp.1267-81, 2000. ,
Shenoy SK. ?-arrestins and cell signaling, Annu Rev Physiol, vol.69, pp.483-510, 2007. ,
Regulation of toll-like receptor-mediated inflammatory response by complement in vivo, Blood, vol.110, pp.228-264, 2007. ,
TLR2 transmodulates monocyte adhesion and transmigration via Rac1-and PI3K-mediated ,
, J Immunol, issue.176, pp.7645-56, 2006.
Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling, Cell, vol.125, pp.943-55, 2006. ,
Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from kupffer cells, Gastroenterology, vol.122, pp.697-708, 2002. ,
C5a negatively regulates toll-like receptor 4-induced immune responses, Immunity, vol.22, pp.415-441, 2005. ,
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses, Vaccine, vol.30, pp.2848-58, 2012. ,
Crosstalk between toll like receptors and C5a receptor in human monocyte derived DCs suppress inflammatory cytokine production, Immunobiology, vol.218, pp.175-80, 2013. ,
Role of complement in induction of antibody production in vivo effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses, J Exp Med, vol.140, pp.126-171, 1974. ,
Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation, Clin Exp Immunol, vol.18, pp.273-82, 1974. ,
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes, J Exp Med, vol.178, pp.1407-1424, 1993. ,
The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens, J Immunol, issue.167, pp.163-72, 2001. ,
A re-evaluation of the role of C3 in B-cell activation, Immunol Today, vol.7, issue.86, pp.90165-90174, 1986. ,
Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response, J Immunol, vol.160, pp.5273-5282, 1998. ,
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity, Science, vol.271, pp.348-50, 1996. ,
C4b-binding protein (C4BP) activates B cells through the CD40 receptor, Immunity, vol.18, pp.837-885, 2003. ,
Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner, Eur J Immunol, vol.43, pp.2441-50, 2013. ,
A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis, J Immunol, vol.175, pp.5379-89, 2005. ,
Cutting edge: complement (C3d)-linked antigens break B cell anergy, J Immunol, issue.179, pp.2695-2704, 2007. ,
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response, Clin Immunol, vol.146, pp.155-64, 2013. ,
T-cell regulation: with complements from innate immunity, Nat Rev Immunol, vol.7, pp.9-18, 2007. ,
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype, Nature, vol.421, pp.388-92, 2003. ,
Complement: central to innate immunity and bridging to adaptive responses, Immunol Lett, vol.97, pp.171-180, 2005. ,
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens, Proc Natl Acad Sci U S A, vol.111, pp.1503-1511, 2014. ,
The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis, J Immunol, vol.193, pp.1278-89, 2014. ,
Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells, J Exp Med, vol.210, pp.257-68, 2013. ,
Absence of signaling into CD4 + cells via C3aR and C5aR enables autoinductive TGF-?1 signaling and induction of Foxp3 + regulatory T cells, Nat Immunol, vol.14, pp.162-71, 2013. ,
The CD46-Jagged1 interaction is critical for human TH1 immunity, Nat Immunol, vol.13, pp.1213-1234, 2012. ,
Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells, J Immunol, issue.181, pp.5158-66, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00325814
The role of complement in CD4+ T cell homeostasis and effector functions, Semin Immunol, vol.25, pp.12-21, 2013. ,
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells, Nat Immunol, vol.11, pp.862-71, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00564091
Decayaccelerating factor modulates induction of T cell immunity, J Exp Med, vol.201, 2005. ,
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo, J Exp Med, vol.201, pp.567-77, 2005. ,
Complement and its role in innate and adaptive immune responses, Cell Res, vol.20, pp.34-50, 2009. ,
Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in jurkat T cells, PLoS One, vol.9, p.85934, 2014. ,
The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes, Mol Immunol, vol.43, pp.643-51, 2006. ,
Intracellular sensing of complement C3 activates cell autonomous immunity, Science, vol.345, p.1256070, 2014. ,
Complement evasion by human pathogens, Nat Rev Microbiol, vol.6, pp.132-174, 2008. ,
Complement evasion of pathogens: common strategies are shared by diverse organisms, Mol Immunol, vol.44, pp.3850-3857, 2007. ,
Functional significance of factor H binding to Neisseria meningitidis, J Immunol, vol.176, pp.7566-75, 2006. ,
Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin, Infect Immun, vol.65, pp.3638-3681, 1997. ,
Yersinia pestis ail recruitment of C4b-binding protein leads to factor I-mediated inactivation of covalently and noncovalently bound C4b: immunity to infection, Eur J Immunol, vol.44, pp.742-51, 2014. ,
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement, PLoS Pathog, vol.6, 2010. ,
Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells, J Biol Chem, vol.288, pp.32172-83, 2013. ,
, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.
Structural basis for complement evasion by lyme disease pathogen Borrelia burgdorferi, J Biol Chem, vol.288, pp.18685-95, 2013. ,
Microbes bind complement inhibitor factor H via a common site, PLoS Pathog, vol.9, 2013. ,
Human factor H interacts selectively with Neisseria gonorrhoeae and results in speciesspecific complement evasion, J Immunol, issue.180, pp.3426-3461, 2008. ,
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates, Nature, vol.458, pp.890-893, 2009. ,
Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola, J Biol Chem, vol.287, pp.12715-12737, 2012. ,
Immune evasion by Staphylococci, Nat Rev Microbiol, vol.3, pp.948-58, 2005. ,
Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing, Results Immunol, vol.3, pp.114-135, 2013. ,
Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tactic, PLoS One, vol.7, p.38407, 2012. ,
Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation, J Immunol, vol.176, pp.3725-3759, 2006. ,
Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo, J Virol, vol.72, pp.8257-63, 1998. ,
Bacterial complement evasion, Mol Immunol, vol.44, pp.23-32, 2007. ,
Immune evasion by pathogenic Leptospira strains: the secretion of proteases that directly cleave complement proteins, J Infect Dis, vol.209, pp.876-86, 2014. ,
Anti-opsonic properties of staphylokinase, Microbes Infect, vol.7, pp.476-84, 2005. ,
Staphylococcal proteases aid in evasion of the human complement system, J Innate Immun, vol.6, pp.31-46, 2014. ,
Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion, J Immunol, issue.186, pp.6445-53, 2011. ,
Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum, Proc Natl Acad Sci U S A, vol.111, pp.427-459, 2014. ,
Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides, J Immunol, vol.193, pp.1855-63, 2014. ,
A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b, J Virol, vol.89, pp.989-98, 2015. ,
A structural basis for complement inhibition by Staphylococcus aureus, Nat Immunol, vol.8, pp.430-437, 2007. ,
Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d, Protein Sci, vol.17, pp.1894-906, 2008. ,
Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b, PLoS One, vol.7, p.47638, 2012. ,
Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogenbinding protein (Efb), J Biol Chem, vol.279, pp.50710-50716, 2004. ,
Inhibition of complement activation by a secreted Staphylococcus aureus protein, J Infect Dis, vol.190, pp.571-580, 2004. ,
Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus, J Biol Chem, vol.282, pp.30051-61, 2007. ,
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b, PLoS Pathog, vol.4, 2008. ,
Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi, J Biol Chem, vol.283, pp.22113-22133, 2008. ,
Staphylococcal complement evasion by various convertaseblocking molecules, J Exp Med, vol.204, pp.2461-71, 2007. ,
Molecular basis for complement recognition and inhibition determined by crystallographic studies of the staphylococcal complement inhibitor (SCIN) bound to C3c and C3b, J Mol Biol, vol.402, pp.17-29, 2010. ,
Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of staphylococcal immune evasion proteins, Adv Exp Med Biol, vol.946, pp.113-146, 2012. ,
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family, J Immunol, issue.183, pp.2565-74, 2009. ,
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor, Nat Immunol, vol.10, pp.721-728, 2009. ,
Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases, J Immunol, issue.184, pp.420-425, 2010. ,
Compstatin: a complement inhibitor on its way to clinical application, Adv Exp Med Biol, vol.632, pp.273-92, 2008. ,
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci, Nat Rev Microbiol, vol.8, pp.393-402, 2010. ,
The complement system in systemic lupus erythematosus: an update, Ann Rheum Dis, vol.73, pp.1601-1607, 2014. ,
Molecular basis of hereditary C1q deficiency -revisited: identification of several novel disease-causing mutations, Genes Immun, vol.12, pp.626-660, 2011. ,
Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis, Lupus, vol.21, pp.1088-97, 2012. ,
Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzymelinked immunosorbent assay, Arthritis Rheum, vol.64, pp.3706-3720, 2012. ,
, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.
Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP, Immunobiology, vol.217, pp.684-91, 2012. ,
Anti-C1q autoantibodies, novel tests, and clinical consequences, Front Immunol, vol.4, p.117, 2013. ,
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes, J Clin Invest, vol.114, pp.679-88, 2004. ,
Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells, J Immunol, issue.183, pp.3512-3533, 2009. ,
Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, pp.1676-87, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01793663
Alternative complement pathway assessment in patients with atypical HUS, J Immunol Methods, vol.365, pp.8-26, 2011. ,
C3 glomerulopathy: a new classification, Nat Rev Nephrol, vol.6, pp.494-503, 2010. ,
Membranoproliferative glomerulonephritis -a new look at an old entity, N Engl J Med, vol.366, pp.1119-1150, 2012. ,
Genetics of hemolytic uremic syndromes, vol.1983, pp.105-119, 2012. ,
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome, J Immunol, issue.182, pp.7009-7027, 2009. ,
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome, J Biol Chem, vol.284, pp.15650-15658, 2009. ,
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome, J Clin Invest, vol.111, pp.1181-90, 2003. ,
Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome, Kidney Int, vol.77, pp.339-388, 2010. ,
Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I, Eur J Immunol, vol.40, pp.172-85, 2010. ,
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome, Blood, vol.112, pp.4948-52, 2008. ,
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proc Natl Acad Sci U S A, vol.104, pp.240-245, 2007. ,
Complement factor B mutations in atypical hemolytic uremic syndromedisease-relevant or benign?, J Am Soc Nephrol, vol.25, pp.2053-65, 2014. ,
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome, Blood, vol.114, pp.2837-2882, 2009. ,
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function, Blood, vol.119, pp.4182-91, 2012. ,
Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations, Blood, vol.125, issue.15, pp.2359-69, 2015. ,
Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome, J Am Soc Nephrol, vol.16, pp.555-63, 2005. ,
Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome, J Am Soc Nephrol, vol.21, pp.2180-2187, 2010. ,
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency, Blood, vol.111, pp.1512-1516, 2008. ,
Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome, J Immunol, issue.189, pp.3528-3565, 2012. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, pp.554-62, 2013. ,
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, pp.1844-59, 2010. ,
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype, J Am Soc Nephrol, vol.24, pp.475-86, 2013. ,
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome, Nat Genet, vol.45, pp.531-537, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01064383
Loss of DGK? induces endothelial cell activation and death independently of complement activation, Blood, vol.125, issue.6, pp.1038-1084, 2014. ,
Genetics of atypical hemolytic uremic syndrome (aHUS), Semin Thromb Hemost, vol.40, pp.422-452, 2014. ,
Factors determining penetrance in familial atypical haemolytic uraemic syndrome, J Med Genet, vol.51, pp.756-64, 2014. ,
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome, Blood, vol.122, pp.282-92, 2013. ,
Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria, J Immunol, issue.179, pp.5543-52, 2007. ,
Autoantibodies against complement components and functional consequences, Mol Immunol, vol.56, pp.213-234, 2013. ,
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation, Kidney Int, vol.82, pp.1084-92, 2012. ,
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies, Kidney Int, vol.82, pp.454-64, 2012. ,
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation, J Clin Invest, vol.120, pp.3702-3714, 2010. ,
, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.
Causes of alternative pathway dysregulation in dense deposit disease, Clin J Am Soc Nephrol, vol.7, pp.265-74, 2012. ,
Complement factor H-related hybrid protein deregulates complement in dense deposit disease, J Clin Invest, vol.124, pp.145-55, 2014. ,
Dimerization of complement factor H-related proteins modulates complement activation in vivo, Proc Natl Acad Sci U S A, vol.110, pp.4685-90, 2013. ,
A hybrid CFHR3-1 gene causes familial C3 glomerulopathy, J Am Soc Nephrol, vol.23, pp.1155-60, 2012. ,
Identification of a mutation in complement factor H-related protein 5 in patients of cypriot origin with glomerulonephritis, Lancet, vol.376, issue.10, pp.60670-60678, 2010. ,
Complement factor H polymorphism and age-related macular degeneration, Science, vol.308, pp.421-425, 2005. ,
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration, Proc Natl Acad Sci U S A, vol.102, pp.7227-7259, 2005. ,
Complement factor H variant increases the risk of age-related macular degeneration, Science, vol.308, pp.419-440, 2005. ,
Complement factor H polymorphism in age-related macular degeneration, Science, vol.308, pp.385-394, 2005. ,
Age-related macular degeneration, Lancet, vol.379, pp.60282-60289, 2012. ,
Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids, Proc Natl Acad Sci U S A, vol.109, pp.13757-62, 2012. ,
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress, Nature, vol.478, pp.76-81, 2011. ,
Rare variants in CFI, C3 and C9 are associated with high risk of advanced agerelated macular degeneration, Nat Genet, vol.45, 2013. ,
Complement factor H related proteins (CFHRs), Mol Immunol, vol.56, 2013. ,
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration, Nat Genet, vol.38, pp.1173-1180, 2006. ,
An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD), Hum Mol Genet, vol.19, pp.4694-704, 2010. ,
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation, J Clin Invest, vol.123, pp.2434-2480, 2013. ,
Autocrine effects of tumor-derived complement, Cell Rep, vol.6, pp.1085-95, 2014. ,
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression, J Immunol, issue.189, pp.4674-83, 2012. ,
Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche, Cancer Res, vol.74, pp.3454-65, 2014. ,
Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response, Immunity, vol.42, pp.767-77, 2015. ,
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement, Cancer Res, vol.64, pp.6310-6318, 2004. ,
Human complement factor H is a novel diagnostic marker for lung adenocarcinoma, Int J Oncol, vol.39, pp.161-169, 2011. ,
Complement factor H or a related protein is a marker for transitional cell cancer of the bladder, Clin Cancer Res, vol.4, pp.2511-2531, 1998. ,
Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma, J Invest Dermatol, vol.134, pp.498-506, 2014. ,
The transcription factor LSF: a novel oncogene for hepatocellular carcinoma ,
, Am J Cancer Res, vol.2, pp.269-85, 2012.
Complement factor H autoantibodies are associated with early stage NSCLC, Clin Cancer Res, vol.16, pp.3226-3257, 2010. ,
PTX3 is an extrinsic oncosuppressor regulating complementdependent inflammation in cancer, Cell, vol.160, pp.700-714, 2015. ,
Complement factor I promotes progression of cutaneous squamous cell carcinoma, J Invest Dermatol, vol.135, pp.579-88, 2015. ,
Successful cure of C1q deficiency in human subjects treated with hematopoietic stem cell transplantation, J Allergy Clin Immunol, vol.133, pp.265-272, 2014. ,
Hereditary angio-oedema, Lancet, vol.379, pp.474-81, 2012. ,
SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience, Rheumatology (Oxford), vol.49, pp.823-827, 2010. ,
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome, Pediatr Nephrol, vol.24, pp.687-96, 2009. ,
An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome, Pediatr Nephrol, vol.29, pp.1967-78, 2014. ,
Frémeaux-Bacchi V; French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, pp.643-57, 2012. ,
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria, N Engl J Med, vol.355, pp.1233-1276, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00599451
Eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.369, pp.1379-80, 2013. ,
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation, Blood, vol.92, pp.1661-1668, 1998. ,
Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria, Blood, vol.123, pp.2094-101, 2014. ,
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy, J Am Soc Nephrol, vol.24, pp.1820-1829, 2013. ,
, Frontiers in Immunology | www.frontiersin.org May, vol.6, p.257, 2015.
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases, Blood, vol.118, pp.4705-4718, 2011. ,
An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H, J Immunol, pp.912-933, 0191. ,
The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complementmediated hemolysis and C3 fragment, Blood, vol.119, pp.6307-6323, 2012. ,
Rational engineering of a minimized immune inhibitor with unique triple-targeting properties, J Immunol, pp.5712-5733, 0190. ,